Study on the Prevalence of Sexually Transmitted Infections with Special Preference to Genital Herpes Infection in

the High Risk Groups Attending STD Clinic in a Tertiary Care Hospital by Arulselvan, S
1 
 
STUDY ON THE PREVALENCE OF SEXUALLY 
TRANSMITTED INFECTIONS WITH SPECIAL 
PREFERENCE TO GENITAL HERPES INFECTION IN 
THE HIGH RISK GROUPS ATTENDING STD CLINIC IN 
A TERTIARY CARE HOSPITAL 
 
 
Dissertation Submitted to 
THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY 
in partial fulfilment of the regulations 
for the award of the degree of 
 
 
M.D. (MICROBIOLOGY) 
BRANCH – IV 
 
 
 
 
 
 
 
 
 
GOVT. STANLEY MEDICAL COLLEGE & HOSPITAL 
THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY 
CHENNAI, INDIA. 
 
APRIL 2015 
 
 
2 
 
DECLARATION 
 
I solemnly declare that this dissertation “STUDY ON THE PREVALENCE OF 
SEXUALLY TRANSMITTED INFECTIONS WITH SPECIAL 
PREFERENCE TO GENITAL HERPES INFECTION AND OTHER 
MICROBIAL INFECTIONS IN THE HIGH RISK GROUPS ATTENDING 
STD CLINIC IN A TERTIARY CARE HOSPITAL” is the bonafide work 
done by me at the Department of Microbiology, Govt. Stanley Medical College 
and Hospital, Chennai, under the guidance and supervision of                       
Prof. Dr. R. SELVI, M.D., Professor of Microbiology, Govt. Stanley Medical 
College, Chennai‐600 001. 
This dissertation is submitted to The Tamil Nadu Dr. M.G.R. Medical 
University, Chennai in partial fulfilment of the University regulations for the 
award of degree of M.D. Branch IV Microbiology examinations to be held in 
April 2015. 
 
Place: Chennai. 
Date:        Dr.S. ARULSELVAN 
 
 
 
 
3 
 
CERTIFICATE 
 
This is to certify that this dissertation entitled “STUDY ON THE 
PREVALENCE OF SEXUALLY TRANSMITTED INFECTIONS WITH 
SPECIAL PREFERENCE TO GENITAL HERPES INFECTION AND 
OTHER MICROBIAL INFECTIONS IN THE HIGH RISK GROUPS 
ATTENDING STD CLINIC IN A TERTIARY CARE HOSPITAL” is the 
bonafide original work done by Dr.S.ARULSELVAN, Post graduate in 
Microbiology, under my overall supervision and guidance in the department of 
Microbiology, Stanley Medical College, Chennai, in partial fulfilment of the 
regulations of The Tamil Nadu Dr. M.G.R. Medical University for the award of 
M.D Degree in Microbiology (Branch IV). 
 
DR.AL.MEENAKSHI SUNDARAM MD.DA, 
DEAN,  PROFESSOR& HOD 
STANLEY MEDICAL COLLEGE 
CHENNAI-600001 
DR.R.SELVI MD, 
DEPARTMENT OF MICROBIOLOGY 
STANLEY MEDICAL COLLEGE 
CHENNAI-600001 
 
                             
  
 
 
4 
 
ACKNOWLEDGEMENT 
My sincere thanks to Dr.AL.Meenakshi Sundaram MD.DA., Dean, 
Government Stanley Medical College and Hospital for giving me permission to 
commence this dissertation and use the resources of this institution. 
I owe my sincere gratitude to Prof. DR.R.SELVI M.D., Professor and 
Head, Department of Microbiology for her unflinching interest, valuable advice, 
excellent guidance and encouragement and freedom given to me throughout his 
study. 
My heartfelt thanks to Prof.Dr.P.Elangovan, M.D.Professor of STD and 
for his encouragement and support. 
I extend my sincere thanks to Assistant Professors Dr.B.Shanthi, M.D., 
and Dr.AVM Balaji, M.D., of Department of Microbiology for their help, 
support, interest and valuable hints. 
I am extremely thankful to Mr.Venkatesan, Statistician for his excellent 
work. I also thank all my senior and junior postgraduates for their timely help, 
cooperation and support. I express many thanks to all the technical staff and 
other staff members of the Department of Microbiology for their kind 
cooperation to carry out this work successfully and I express my heartful thanks 
to my wife Dr.J.Sashirekha and my daughter. I also extend my thanks to all the 
patients who participated in my study. 
5 
 
CONTENTS 
 
 
SL.NO                TITLE                                                    PAGE NO 
 
1.                  INTRODUCTION                                              1 
 
 2. AIMS AND OBJECTIVES                                8 
 
 3. REVIEW OF LITERATURE  9 
 
4. MATERIALS AND METHODS  58   
 
  5. RESULTS  84 
 
 6.  DISCUSSION        104 
 
  7.  SUMMARY      111 
 
  8.  CONCLUSION     114 
 
  9. ANNEXURES      116  
     
I) PROFORMA  
II) APPENDIX 
  III)BIBLIOGRAPHY 
IV) KEY TO MASTER CHART 
V) MASTER CHART 
 
ABSTRACT
TITLE:STUDY ON THE PREVALENCE OF SEXUALLY
TRANSMITTED INFECTIONS WITH SPECIAL PREFERENCE TO
GENITAL HERPES INFECTION IN THE HIGH RISK GROUPS
ATTENDING STD CLINIC IN A TERTIARY CARE HOSPITAL.
INTRODUCTION:
High risk group of people attending the STD clinic including Female sex
workers, males having sex with males and transgenders harbors the high risk of
encountering the sexually transmitted infectionsmaking them more vulnerable
in acquiring sexually transmitted infections and also spreading it to the
community.
AIMS AND OBJECTIVES:
• To determine the prevalence of sexually transmitted viral infections like
Human immunodeficiency virus, Herpes simplex virus 2, Human
papilloma virus 16 and 18, hepatitis B and C virus and Gonorrhea,
Bacterial Vaginosis, syphilis, vaginal candidiasis and Trichomoniasis
among asymptomatic high risk groups of males who have sex with males,
Transgenders and female sex workers attending STD clinic in a tertiary
care hospital.
• Comparison of seroprevalence of  herpes simplex virus 2 and genital viral
shedding among the high risk groups
• To determine the prevalence of high risk Human Papilloma virus 16 & 18
viral shedding among the high risk groups
MATERIALS AND METHODS:
Specimen collection and processing:
Samples from Female sex workers, Males having sex with males, transgender
including Endocervical swabs, High vaginal swab, rectal swabs, Urethral swabs,
pharyngeal swab and bloodare collected and processed by standard
microbiological methods. Pharyngeal and rectal specimens were obtained using
cotton swabs. Rectal specimens were obtained either by blind anal swabbing or,
via anoscopy.Cervical specimens taken with Dacron swabs are preserved with
70% ethanol solution for molecular analysis.Serological tests done for ELISA
HIV, HSV2 IgM and IgG ELISA. Serological testing done for Syphilis with
RPR test and Confirmation with Treponema pallidum hemagglutination test
(TPHA).Rapid card test done for hepatitis B and Hepatitis C.
PCR done from the anogenital swabs for HSV2, HPV 16 and 18
RESULTS:
Among the high risk groups taken for study the female sex workers (57%)
were the commonest and most of them are unmarried 106(53%) with
predominant mode of sexual contact was heterosexual mode (57%) and 41%
had unprotected sexual act (without condoms).
Out of 200 asymptomatic cases Neisseria gonorrhoeae (1), Trichomonas
vaginalis (1), Candida albicans 9 and non albicans 9, Gardernerella vaginalis
(4) were isolated.  HIV reactivity (8), HbsAg (1) and RPR reactivity (7). IgM,
IgG antibodies for HSV 2 is (16) and IgG (67) respectively and PCR for HSV2
is 20.Speciation of the candida species showed candida Human Papilloma Virus
18 E7 and 18 E7 in 4 with one positive for both HPV 16 and 18 co infection.
CONCLUSION:
Out of 20 PCR positives the IgM was positive in only 16.There was
genital viral shedding even in the absence of IgM antibodies. So molecular
methods are necessary to know about the genital viral shedding.
Continuous efforts are needed to encourage individuals to adopt safer
sexual. Prophylactic strategies regarding antiviral therapy for HSV2 infected
individuals and vaccination for HPV to be considered in the high risk groups.
Key words-Sexually transmitted infections, High risk groups, Genital Herpes,
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INTRODUCTION 
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Historically sexually transmitted diseases are as old as mankind, scholar’s claim 
that the references of venereal diseases has been in biblical versions. The 
incidence of four sexually transmitted infections like Trichomoniasis, 
Gonorrhoea, Chlamydiasis and syphilis is estimated to be 489.9 million 
worldwide
1
. 
  Even with the increased awareness and availability of effective treatment 
Sexually Transmitted Infections are still at a large, causing significant morbidity 
and mortality worldwide. They remain to be the important cause of acute 
illnesses, impotence, infertility, long term disability and death globally. 
 There are over more than 20 causes of sexually transmitted infections 
including bacterial, viral and parasitic agents. The prevalence of bacterial causes 
of STIs like syphilis, Gonorrhoea, Chlamydiasis, Bacterial vaginosis and the 
parasitic Trichomoniasis is more in the developing countries compared to 
industrialised nations where there is STIs of viral infections is more but now the 
trend has changed due to the spread of HIV throughout the world making the 
incidence of viral infections like Herpes simplex virus 2, Human papilloma 
virus, Hepatitis B and Hepatitis C and Cytomegalovirus predominate globally. 
This increased incidence of viral infections can also be due to the increased 
awareness of people seeking healthcare facilities, increased use of broad 
spectrum antibiotics and the effectiveness of syndromic approach of treatment
2
. 
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 Sexually transmitted infections increase the risk of acquiring and 
transmission of HIV so the presence of untreated STIs (ulcerative or non-
ulcerative) increases the risk of acquiring and transmitting the HIV by a factor 
of ten
3. 
In developing countries STIs and its complications are the one of the top 
five disease categories for which adults seeks healthcare facilities. 
  Hepatitis B virus and Hepatitis C virus infection is an important health 
problem in the developing countries like India. Carrier rates of HBV and HCV 
in India was 3% and 1-1.5% respectively and about 2 lakh people die annually 
because of HBV or HCV alone
6
.  About 240 million people are affected with 
chronic HBV infection
5 
worldwide.  Since HBV and HIV shares the same route 
of transmission the prevalence of HBV in the high risk population attending the 
STD clinic is more compared to the general population
4
.  
 Various population-based studies conducted in developed and developing 
countries have reported Genital Herpes Simplex Virus 2 Prevalence in the range 
of 5.6-42.2%
7
.Genital herpes virus infection is an important risk factor for the 
infection of HIV and also for syphilis. The prevalence of HSV2 varies 
according to the population taken for the study. For instance the prevalence of 
HSV2 in the high risk group attending the STD clinic is about 70% and the 
prevalence in the antenatal mothers is about 11.3% in developing countries
7
. 
 Mostly genital herpes infection remains asymptomatic / subclinical and 
undiagnosed. As per WHO treatment regime 25 cases of first/primary episode 
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of genital herpes infection is missed clinically. Genital herpes is mainly caused 
by Herpes simplex virus 2 and also rarely by herpes simplex virus 1. Both the 
symptomatic and asymptomatic patients will be having the intermittent viral 
shedding from their genital tracts during which they will be transmitting the 
disease
9
 and in the asymptomatic patients genital shedding of virus happens in 
10% of days during which the patient don’t have any signs or symptoms
13 
. The 
prevalence of genital viral shedding during pregnancy ranges from 0.5 to 0.6%
14
 
by which the child can acquire the infection. Neonatal infection is mostly 
symptomatic and lethal which in the absence of intervention will be around 
80%
14. 
The High risk patients with Genital herpes will be potentially spreading 
the genital herpes to their contacts and spouses making them vulnerable to other 
infections like HIV and syphilis. 
 So it is important to control the viral shedding thereby preventing the 
disease spread. With antiviral therapy the genital viral shedding can be 
reduced
9
.So it is necessary to adopt a serological/Molecular methods to 
diagnose the asymptomatic high risk cases and for the intervention measures 
like prophylactic antiviral treatment and protective (barrier) measures. 
 Human papillomavirus (HPV) is the most common sexually transmitted 
viral infection and studies have estimated that globally 50-80% of sexually 
active men and women are infected with the virus at least once during their 
lifetimes. Globally about 291 million women are HPV DNA carriers. About 
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7.9% of women in the general population are estimated to harbor cervical HPV 
infection at a given time. 
 India has a population of 432.20million women in the age group of 15 
years and above who are at risk of developing cervical cancer. Currently it has 
been estimated that every year 1,22,844 women are diagnosed with cervical 
cancer and  67477 die from the disease. Cervical cancer ranks as the 2
nd
most 
frequent cancer among women in India and84.1% of invasive cervical cancers 
are attributed to HPVs 16 or 18
22
.The HPV virus is associated not only with 
cervical cancer but also with anal, vaginal, penile and oral cancers. Besides 
HPV, genital tract infections from other organisms like Trichomonas vaginalis 
(TV), Chlamydia trachomatis and Herpes simplex virus (HSV) type 2 have also 
been implicated in cervical cancers in women. Human Immunodeficiency virus 
(HIV) positive women have significantly higher prevalence of genital squamous 
intraepithelial lesions and of multifocal HPV related diseases
29
.  
Studies have indicated that a high number of lifetime partners may lead to 
a higher transmission of HPV leading to higher cervical cancer rates. In female 
sex workers (FSWs), the risk of HPV infection and cervical cancer is especially 
high. In addition, HPV can be transmitted from FSWs to the general population 
through clients thereby increasing the prevalence of the virus
28
. 
 The female sex workers (FSW), the men having sex with men (MSM) 
and transgender (TG) are at high risk of contracting various sexually transmitted 
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infections (STI) due to their high risk sexual behaviors. Co-existence of HPV 
and other sexually transmitted infections can increase their predisposition to 
different ano-genital cancers
29
. 
      Neisseria gonorrhoeae infection one of the commonest STIs which is 
estimated to be about 106.1 million new cases worldwide. The prevalence of 
N.gonorrhoeae in the adult males(age15-49yrs) is 1% in south and southeast 
Asia
3
.N.gonorrhoeae apart from being a risk factor for acquiring HIV it is also 
the causative factor for PID, infertility, ectopic pregnancy and chronic pelvic 
pain. There has been increased incidence in the treatment resistant strains of N. 
gonorrhoeae making the management of gonococcal infection a challenge. 
There has been wide difference in the resistance pattern throughout the India 
with penicillin resistance being 20% to 79%, ciprofloxacin 10.6% to 100% and 
tetracycline resistance 0% to 45.6%
8
. So studying about the treatment resistant 
strains will help in updating the local treatment guidelines. 
 Syphilis caused by Treponema pallidum is one of the oldest known STI in 
the world with the worldwide prevalence of 14.3 million.Eventhough the 
prevalence is declining currently there has been increased incidence among the 
high risk population especially men having sex with men co-infected with 
HIV
10
.This change in trend may be due to the spread of HIV and change in the 
sexual behaviour pattern. Screening and diagnosing syphilis with RPR and 
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TPHA in the high risk groups will help in curtailing the spread of syphilis and 
HIV among these high risk groups and also to the general population. 
 Vaginal discharge in the reproductive age group of women is most 
commonly is caused by Trichomoniasis, bacterial vaginosis and vaginal 
candidiasis of which 276.4 million  total number of new cases of   Trichomonas 
vaginalis is seen globally
1 
and out of which 28.7 million cases were in southeast 
Asian region with the male and female prevalence is about 5.6% and 0.6% 
respectively.  Trichomoniasis is the commonest non-viral STI and it had been 
suggested as one of the important causes of non gonococcal urethritis and also it 
amplifies the risk of HIV transmission
11
.  
 Bacterial vaginosis is one of the commonest causes of vaginal discharge 
in the women of child bearing age group and associated with the low birth 
weight  and many studies throughout the world had shown the association of 
bacterial vaginosis with other STIs like Genital herpes infection, 
Trichomoniasis ,Gonococcal infection and HIV 
15
.   
 Vulvovaginal candidiasis which is said to be affecting 75% of women in 
their lifetime can be asymptomatic but also causes significant morbidity 
including vaginal discharge, dysuria, itching and dyspareunia and also 50% of 
women suffer from recurrent episodes
16. 
 Sexually transmitted infections causes significant morbidity to the high 
risk patients and also making them more vulnerable in acquiring sexually 
13 
 
transmitted infections like HIV and also spreading it to the community 
.Asymptomatic Genital herpes infection plays a significant role in spreading the 
disease and also increasing the vulnerability of acquiring the other sexually 
transmitted infections So the purpose of this study is to evaluate the prevalence 
of sexually transmitted infections so that early diagnosis and treatment would 
cure the disease as well preventing them from transmitting the sexually 
transmitted infections. 
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AIMS & OBJECTIVES 
 
• To determine the prevalence of sexually transmitted viral infections like 
Human immunodeficiency virus, Herpes simplex virus 2, Human 
papilloma virus 16 and 18, hepatitis B and C virus and Gonorrhea, 
Bacterial Vaginosis, syphilis,vaginal candidiasis and Trichomoniasis 
among asymptomatic high risk groups of males who have sex with males, 
Transgenders and female sex workers attending STD clinic in a tertiary 
care hospital. 
• Comparison of seroprevalence of  herpes simplex virus 2 and genital viral  
shedding among the high risk groups 
• To determine the prevalence of high risk Human Papilloma virus 16 & 18  
viral shedding among the high risk groups  
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Sexuality is a fundamental aspect of human life, carrying the potential to 
create new life and fulfilling both personal and social needs. Sexual health as 
per WHO is defined as” Sexual health is a state of physical, mental and social 
well-being in relation to sexuality. It requires a positive and respectful approach 
to sexuality and sexual relationships, as well as the possibility of having 
pleasurable and safe sexual experiences, free of coercion, discrimination and 
violence”
19
 .To attain this sexual health we need to have proper understanding 
of multi-level determinants of STIs and to refocus about the prevention and 
control strategies of sexually transmitted infections.   
 The term sexually transmitted infections had undergone various changes 
over the century initially known as ‘Venereal disease’ and later on as ‘sexually 
transmitted diseases’ finally as ‘sexually transmitted infection’ which is a 
broader terminology including those who have infection and spreading it 
without having the disease. 
 Sexually transmitted infections are the infections which are spread by 
person to person sexual route including vaginal, anal, oral and skin to skin 
contact and some sexually transmitted infections which are also spread through 
non sexual routes like blood transfusion, IV drug abuse, congenital, child birth 
and breast feeding.  
 There are more than 30 causes of STI which includes bacterial, viral, 
fungal and parasitic organisms. Of these organisms 8 organisms are linked with 
18 
 
the greater incidence of illnesses. Among these 8 infections four of the currently 
curable diseases are syphilis, Trichomoniasis, Chlamydiasis and gonorrhoea and 
other four are viral infections including HIV, Hepatitis virus, Herpes virus and 
HPV which are even though incurable but can be mitigated or modulated with 
treatment 
17
 . 
 Among the STIs the infections like HIV, syphilis, gonorrhoea and 
hepatitis B is seen more in the high risk populations like commercial sex 
workers, men having sex with men (MSM) and the drug abusers whereas other 
infections like genital herpes, human papilloma virus infection and chlamydial 
infection can easily spread among the low risk population
18
. 
 STIs causing genital ulcers are more important as the genital ulcers 
increases the risk of acquiring the HIV infection and also shedding the virus and 
thereby increasing the spread of the disease. Causes of genital ulcers are 
syphilis, herpes, chancroid, Lymphogranuloma venereum and Donovanosis of 
which the syphilis, chancroid and herpes are important and commonest causes. 
With increased efforts to control chancroid and syphilis has led Genital herpes 
to be commonest cause in the developing countries
17
.    
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VIRAL CAUSES OF STI 
GENITAL HERPES INFECTION 
‘Herpes’ a Greek word meaning ‘to crawl or creep’ referring to the 
spreading nature of the herpetic lesions. The references of lesions similar to 
genital herpes have been seen in Sumerian tablet from the third millennium BC 
and in the Ebers Papyrus (circa 1500 BC). 
Genital herpes was more recognised after the advances in science of 
virology in the middle 20
th
 century and also the first reliable antiviral agent 
Acyclovir was  developed to treat Genital and oral herpes in the early 1980s
19
.  
 Herpes simplex virus is classified as alpha herpes virus under the herpes 
virus family .these alpha viruses are fast growing, cytolytic and have latent 
infection in neurons of the host. 
Genital herpes is predominantly caused by human herpes virus 2 and also 
by human herpes virus 1 it affects the mucosal surfaces and damaged cutaneous 
sites .HSV regardless of the type first enters the sensory nerves during the 
primary infection and then remains dormant in the neuronal cell body and 
causes recurrent infection and also asymptomatic shedding of virus from the 
genital region. 
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VIRION STRUCTURE 
The herpes simplex virus is a spherical particle with the diameter of 
186nm and contains four structures 1. Core containing the viral DNA 
2.icasohedral capsid surrounding the core with 162 capsomeres3. Unstructured 
proteinacous layer called tegument surrounding the capsid 4. Outer lipid bilayer 
with spikes in its surface. 
The genome of herpes virus DNA is linear, double stranded DNA 
molecule(molecular weight 100x10
6 
units)that encodes more than 90 
transcription units with 84 identified proteins and the genomic subtype of HSV1 
and HSV2 are similar .the overall genomic sequence  homology between the 
two types is around 50% and the protein sequence homology is around 
80%.many type specific regions unique to HSV1 and HSV2 exists in the 
genome only based on  these  type specific regions serological assays 
distinguish between the HSV1 and HSV2
18
. 
REPLICATION CYCLE 
Viral replication cycle has both cytoplasmic and nuclear phases. Once the 
virus fusion and entry happens in the host cell the nucleocapsid enters the 
cytoplasm and many viral proteins are released .These viral proteins shutdowns 
the host cell protein synthesis and turns on the transcription of early viral 
replication α genes and the synthesis of β polypeptide which are the regulatory 
21 
 
proteins and enzymes needed for DNA replication. The γ group of genes 
constitutes for the most of the structural proteins of virus. 
Viral DNA is transcribed by RNA polymerase II.Herpes simplex viruses 
DNA encodes for large number of enzymes involved in the DNA synthesis 
which is different in compared with the other DNA viruses and these enzymes 
are good targets for the antiviral drugs. Viral DNA synthesised is packaged into 
nucleocapsid and then these nucleocapsids are then transported to the cell 
surface by vesicular movement. The length of the replication cycle is about 18 
hours.MicroRNAs which are single stranded (~22 nucleotides) plays important 
role in entry in to and exit of the virus from the latent phase of virus life cycle. 
PATHOGENESIS 
Genital Herpes simplex infection will be transmitted from the virus 
excreting infected person to the susceptible contact. Herpes simplex virus 
causes necrosis of the infected cell along with the inflammatory response. The 
pathologic changes due to the viral infection will be ballooning of infected cell, 
intranuclear Cowdry type A inclusion body, margination of chromatin and 
multinucleate giant cell formation. 
CLINICAL FEATURES 
Genital herpes caused by both HSV1 and HSV2 viruses. The primary 
genital herpes infection occurring in the absence of antibodies can be severe 
22 
 
lasting up to about 3 weeks. The genital herpes infection is characterised by 
vesiculoulcerative lesion of the penis in male and vesiculoulcerative lesion of 
the cervix, vagina, vulva and perineum in females. These painful lesions will be 
associated with fever, malaise, dysuria and inguinal lymphadenopathy. The 
complications will be extra genital lesions in about 20% of cases and aseptic 
meningitis in about 10% of cases. Viral excretion may be persisting for about 3 
weeks
20
.as there is antigenic cross reactivity exists between HSV1 and HSV2, 
the prior infection with HSV1 in a patient may offer some protection during the 
subsequent HSV2 infection making the genital infection less severe. 
LATENT INFECTION 
One of the interesting ability of the herpes virus biology is that’s its 
ability to extend a lifelong latent infection in human host. After the spread from 
the tissue, primary site of infection the virus enters the neuronal axons the virus 
travels in a retrograde manner to reach the nucleus of the nerve cell body where 
the lytic gene expression is suppressed and the latent associated transcript 
(LAT) is expressed.  
 If the virus reactivates then the infectious virus is travels in the ante grade 
manner to reach the cells at or near the initial site of infection. This reactivated 
herpes infection can be asymptomatic or the lesions can vary from small 
punctate lesions not visible to naked eye to severe debilitating lesion depending 
upon the immune status of the individual. The recurrence of genital herpes 
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infection is common and tend to be mild .Few vesicles appear and tend to heal 
within 10 days. Sometimes the asymptomatic anogenital viral shedding may be 
very minimal that it lasts only for 24 hours. 
 The reactivation of latent viral can be due to either local causes physical 
injury to the initial site of infection or can be due to the systemic causes like 
fever, exposure to UV light and physical, emotional stress. 
 The frequency of recurrences in men is about 2.7 per 100 patient days and 
whereas for females it is 1.9 per 100 patient days. Overall the frequency of 
recurrences is about 60% and approximately about 90% of HSV2 infected 
patients will have one or more recurrences per year, 38% may be having six 
recurrences and 20% having 10 recurrences
14
. 
 Viral shedding in the commercial sex workers with the age group of 20 to 
29 is about 12% whereas in the older age groups of commercial sex workers the 
viral excretion is about 6% only. The HSV2 viral shedding among the middle 
and upper socioeconomic women is 0.3 to 0.2% respectively which is much 
lesser compared to the women attending the STD clinic
14
.  
LABORATORY DIAGNOSIS 
CYTOPATHOLOGY 
 The skin scrapping’s obtained from the base of the vesicle stained with 
Giemsa stain will show the multinucleate giant cells which is indicative of 
herpes virus (HSV1, HSV2 and Varicella zoster) infection. 
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VIRAL ISOLATION 
 Virus can be isolated from CSF, throat, urine, stool, nasopharynx and 
conjunctiva. Viral isolation is the definite diagnostic method.it is easy to 
cultivate and the cytopathic effects appear by 2-3 days.it is then identified by 
NT test or immunofluorescence staining with specific antiserum. Typing is done 
by monoclonal antibody or restriction endonuclease method. 
POLYMERASE CHAIN REACTION 
It is the most specific and sensitive method .By using primers from an 
HSV DNA sequence that was common to both HSV types 1 and 2 (either the 
gB (viral envelope glycoprotein)or DNA polymerase genes) we can identify the 
causes of Genital Herpes infection irrespective of its type. 
SEROLOGY 
 Antibodies start to appear 4-7 days after the infection and will reach peak 
2-4 weeks. Diagnostic value of serological assay is limited because of sharing 
of multiple antigens between HSV1 and HSV2. Only the type specific HSV 
antibodies serological tests will be of diagnostic value.  
HUMAN PAPILLOMA VIRUS INFECTION 
 It is the most common viral infection of the reproductive tract and 
worldwide about 660 million people are having HPV genital infections, an 
estimated 6.2 million new infections are occurring annually in the United States. 
25 
 
The peak incidence of HPV infections occurs in adolescents and young adults 
under 25 years of age
20
. 
The Papillomaviridae family, a very large virus family is divided into 16 genera, 
of which five contain members that infect humans (Alpha-, Beta-, Gamma-, 
Mupa-, and Nupapapillomavirus). Using the molecular criteria more than 100 
distinct human papillomavirus (HPV) types have been recovered. 
 The Human Papilloma Virus of greatest medical importance is those 
which are associated with genital and mucosal cancers and they are members of 
the alpha genus. Most alpha Papilloma Virus infect the external genitals, genital 
and non-genital mucosal surfaces are collectively called as genital-mucosa 
types. The high risk types that are associated with cervical cancer are species 5, 
6, 7, 9, 11, 16 and 18. HPV-16, the type found most frequently in cervical 
cancer, is a member of species 9, whereas the next most common cancer-
associated type, HPV-18, is a member of species 7. HPV6, which causes most 
cutaneous genital warts, is a species 10 member. 
STRUCTURE: 
It is an epitheliotropic, non-enveloped, double stranded DNA virus with 
the diameter of about 55nm having genome of about 8kbp which is surrounded 
72 capsomers having nucleocapsid. 
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REPLICATION: 
The papillomaviruses are highly species-specific and they have a specific 
predilection for squamous epithelial cells. The Papillomaviruses infection can 
be divided into early and late stages. The virus must will infect the basal cell to 
establish a persistent lesion and the late gene expression, capsid proteins 
synthesis, vegetative viral DNA synthesis, and assembly of virions occur only 
in terminally differentiating squamous epithelial cells. 
PATHOGENESIS  
Viral particles are released from the surface of papillomatous lesions will 
be transmitted by close contact. HPV genital infections are sexually transmitted 
and the most common sexually transmitted disease in the United States.                          
Cervical cancer is the second most frequent cancer in women worldwide (about 
500,000 new cases annually) and is a major cause of cancer deaths in 
developing countries. Cervical cancer develops slowly taking years to 
decades
20
. Even though multiple factors are involved in progression to 
malignancy the persistent infection with a high-risk HPV is a important 
component to the process of malignancy. 
CLINICAL FEATURES 
HPVs are accepted as the cause of anogenital cancers. Over 99% of 
cervical cancer cases and over 80% of anal cancer cases are linked to genital 
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infections with HPVs. Although many different HPV types cause genital 
infections, HPV-16 or HPV-18 is found most frequently in cervical carcinomas, 
though some cancers contain DNA from other types, such as HPV type 31. 
Epidemiologic studies indicate that HPV-16 and HPV-18 are responsible for 
more than 70% of all cervical cancers, with type 16 being most common. 
 Condylomas are usually exophytic lesions that are frequently multiple. 
They can arise anywhere on the external genitalia and can be found 
simultaneously in multiple sites. In men, they occur most commonly on the 
penis and anus, and in women on the perineum and anus. The anus can develop 
multiple lesions that coalesce to surround the anal canal. Most condylomas are 
usually self-limited, regressing spontaneously or after local treatment, but some 
lesions can persist for years.  
As with other HPV infections, genital warts, when they arise in patients 
with impaired cellular immunity, can be extremely refractory to treatment. They 
can also increase in size and number during pregnancy, and regress following 
delivery. This sequence of events may also be a reflection of the immune 
suppression associated with pregnancy. 
About 90% of genital warts are caused by HPV-6 or HPV-11, which are 
closely related to each other, with HPV-6 predominating. Other HPV types, 
including HPV-16, may also be found in these lesions. Most of these lesions 
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contain HPV-16, but the rate of transition to frank malignancy appears to be 
much lower for the external genitalia than for the cervix.  
Anal cancer is associated with high-risk HPV infection. 
Immunocompromised patients are especially at risk, as are men who have sex 
with men. Oropharyngeal cancers, a subset of head and neck squamous cell 
carcinomas, are also linked to HPV infections, especially by type 16. 
The role of men as carriers of HPV as well as vectors for transmission of 
infections is well documented; however, most penile HPV infections in men are 
subclinical and do not result in HPV-associated disease. 
Anogenital warts are usually (90%) caused by low-risk HPV types 6 and 
11. HPV-6 and HPV-11 cause benign genital condylomas. The infection is 
acquired during passage through the birth canal of a mother with genital warts.  
There is a high prevalence of HPV DNA in normal skin from healthy 
adults. It appears that these asymptomatic HPV infections are acquired early in 
infancy. A great multiplicity of HPV types are detected in normal skin. 
Transmission is thought to occur from those in close contact with the child, with 
a high concordance (about 60%) between types detected in infants and their 
mothers. 
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Immunosuppressed patients experience an increased incidence of warts 
and cancer of the cervix. All HPV-associated cancers occur more frequently in 
persons with HIV/AIDS. 
PREVENTION & CONTROL 
Vaccines against HPV are expected to be a cost-effective way to reduce 
anogenital HPV infections, the incidence of cervical cancer, and the HPV-
associated health care burden. A quadrivalent HPV vaccine was approved in the 
United States in 2006 and a bivalent vaccine in 2007. Both are noninfectious 
recombinant vaccines containing virus-like particles composed of HPV L1 
proteins. The quadrivalent vaccine contains particles derived from HPV types 6, 
11, 16, and 18, whereas the bivalent vaccine contains particles from types 16 
and 18. Both vaccines are effective at preventing persistent infections by the 
targeted HPV types and the development of HPV-related genital precancerous 
lesions. They are not effective against established HPV disease. Adolescent and 
young adult females make up the initial target population for vaccination. It is 
not known how long vaccine-induced immunity lasts, but it appears to extend 
for at least 5 years
14
. 
HPV vaccines are not recommended for pregnant females. 
 
 
30 
 
HEPATITIS B 
Hepatitis B virus infection is distributed worldwide. There are more than 
250 million carriers of Hepatitis B Worldwide and 1 million deaths a year are 
due to to HBV-related liver disease and hepatocellular carcinoma. 
 Depending on the age at time of infection and the transmission routes, 
response of the infection vary.  Mostly individuals infected as infants develops 
chronic infections as they reach adulthood they are subject to liver disease and 
are at high risk of developing hepatocellular carcinoma. There is no any 
seasonal trend for HBV infection and no high predilection for any age group 
 High-risk groups 
 Highly promiscuous persons, parenteral drug abusers, health care 
personnel, multiply transfused patients, organ transplant patients, haemodialysis 
patients and staff, and new-born infants born to mothers with hepatitis B.It also 
spreads by improperly sterilized syringes, needles, or scalpels and even by 
tattooing or ear piercing. After the institution of mandatory screening of blood 
donors for HBsAg, the number of cases of transfusion-associated hepatitis has 
been reduced dramatically.  
Routes of transmission  
More than 1 billion virions  is present in one  millilitre of blood from an 
HBeAg-positive carrier and as these viruses are resistant to drying, it should be 
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considered that all bodily fluids from HBV-infected patients are infectious 
.HBsAg can be detected in body fluids like saliva, nasopharyngeal washings, 
semen, menstrual fluid, and vaginal secretions as well as in blood 
Transmission from carriers to close contacts by the oral route or by sexual 
or other intimate exposure occurs. There is strong evidence of transmission 
from persons with subclinical cases and carriers of HBsAg to homosexual and 
heterosexual long-term partners. Transmission by the faecal-oral route has not 
been documented. Subclinical infections are common, and these unrecognized 
infections represent the principal hazard to hospital personnel. 
Health care personnel (medical and dental surgeons, pathologists, other 
physicians, nurses, laboratory technicians, and blood bank personnel) have a 
higher incidence of hepatitis and prevalence of detectable HBsAg or anti-HBs 
than those who have no occupational exposure to patients or blood products. 
The risk that these apparently healthy HBsAg carriers (especially medical and 
dental surgeons) represent to the patients under their care remains to be 
determined but is probably small. 
Hepatitis B infections are common among patients and staff of 
haemodialysis units. As many as 50% of the renal dialysis patients who contract 
hepatitis B may become chronic carriers of HBsAg compared with 2% of the 
staff group, emphasizing differences in the host immune response. Family 
contacts are also at increased risk. 
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Incubation period 
The incubation period of hepatitis B is 50–180 days, with a mean 
between 60 and 90 days. It appears to vary with the dose of HBV administered 
and the route of administration, being prolonged in patients who receive a low 
dose of virus or who are infected by a nonpercutaneous route. 
Structure 
HBV is classified as a hepadnavirus. 
Virion: 
It is About 42 nm in diameter overall (nucleocapsids, 18 nm) .Electron 
microscopy of HBsAg-positive serum reveals three morphologic forms the most 
numerous are spherical particles measuring 22 nm in diameter .These small 
particles are made up exclusively of HBsAg––as are tubular or filamentous 
forms, which have the same diameter but may be over 200 nm long––and result 
from overproduction of HBsAg. Larger, 42-nm spherical virions (Dane 
particles) are less frequently observed. 
Genome: 
One molecule of double-stranded DNA, circular, 3.2 kbp. In virion, 
negative DNA strand is full length and positive DNA strand is partially 
complete. The gap must be completed at beginning of replication cycle.  
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There are four open reading frames that encode seven polypeptides. 
These include structural proteins of the virion surface and core, a small 
transcriptional Trans activator (X), and a large polymerase (P) protein that 
includes DNA polymerase, reverse transcriptase, and RNase H activities. The S 
gene has three in-frame initiation codons and encodes the major HBsAg, as well 
as polypeptides containing in addition pre-S2 or pre-S1 and pre-S2 sequences. 
The C gene has two in-frame initiation codons and encodes HBcAg plus the 
HBe protein, which is processed to produce soluble HBeAg. 
Replication of Hepatitis B Virus 
The infectious virion attaches to cells and becomes uncoated. In the 
nucleus, the partially double-stranded viral genome is converted to covalently 
close circular double-stranded DNA (cccDNA). The cccDNA serves as template 
for all viral transcripts, including a 3.5-kb pregenome RNA. The pregenome 
RNA becomes encapsulated with newly synthesized HBcAg. Within the cores, 
the viral polymerase synthesizes by reverse transcription a negative-strand DNA 
copy. The polymerase starts to synthesize the positive DNA strand, but the 
process is not completed. Cores bud from the pre-Golgi membranes, acquiring 
HBsAg-containing envelopes, and may exit the cell. Alternatively, cores may be 
reimported into the nucleus and initiate another round of replication in the same 
cell. 
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INCUBATION PERIOD 
50–180 days 
CLINICAL FINDINGS 
In viral hepatitis, onset of jaundice is often preceded by gastrointestinal 
symptoms such as nausea, vomiting, anorexia, and mild fever. Jaundice may 
appear within a few days of the prodromal period, but anicteric hepatitis is more 
common. 
Extra hepatic manifestations of viral hepatitis (primarily type B) which 
are proposed to be due to  circulating immune complexes includes transient 
serum sickness-like prodrome consisting of fever, skin rash, and polyarthritis, 
necrotizing vasculitis (polyarteritisnodosa) and glomerulonephritis. 
Uncomplicated viral hepatitis rarely continues for more than 10 weeks without 
improvement. Relapses occur in 5–20% of cases and are manifested by 
abnormalities in liver function with or without the recurrence of clinical 
symptoms. 
 Sometimes acute viral hepatitis can cause more extensive damage 
preventing organised liver cell regeneration. Only 1–2% of jaundiced patients 
with hepatitis B have such fulminant or massive hepatocellular necrosis. It is ten 
times more common in those coinfected with HDV than in the absence of HDV. 
35 
 
Both HBV and HCV have important roles in the development of 
hepatocellular carcinoma that may appear many (15–60) years after 
establishment of chronic infection. 
LABORATORY FEATURES 
HBsAg is generally evident 2–6 weeks in advance of clinical and 
biochemical evidence of hepatitis and continues throughout the clinical course 
of the disease but characteristically disappears by the sixth month after 
exposure. In the initial stages of disease high concentrations of HBV particles 
may be present in the blood (up to 10
10
 particles/mL) HBV DNA polymerase 
activity, HBV DNA, and HBeAg are characteristic of the viremic stage of 
hepatitis B, occur concomitantly or shortly after the first appearance of HBsAg 
during which communicability is highest at this time.  
Anti-HBc antibody is against the 27-nm internal core component of HBV 
High levels of IgM-specific anti-HBc are often detected at the onset of clinical 
illness. Its appearance indicates the viral replication. Antibody to HBsAg is first 
detected at a variable period after the disappearance of HBsAg. It is present in 
low concentrations. Before HBsAg disappears, HBeAg is replaced by anti-HBe, 
indicating the start of resolution of the disease. Anti-HBe levels often are no 
longer detectable after 6 months. 
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HBV chronic carriers 
By definition, HBV chronic carriers are those in whom HBsAg persists 
for more than 6 months in the presence of HBeAg or anti-HBe. HBsAg may 
continue for years after loss of HBeAg. In contrast to the high titers of IgM-
specific anti-HBc detected in acute disease, low titers of IgM anti-HBc are 
found in the sera of most chronic HBsAg carriers. Small amounts of HBV DNA 
are usually detectable in the serum as long as HBsAg is present. 
The most useful detection methods are ELISA for HBV antigens and 
antibodies and PCR for viral DNA. 
PREVENTION & CONTROL 
Vaccine 
Since 1982 vaccine for hepatitis B is available. The early vaccine was 
prepared by purifying and formalin/heat treated HBsAg associated with the 22-
nm particles from healthy HBsAg-positive carriers. Recent plasma-derived 
vaccines have been substituted by recombinant DNA-derived vaccines 
consisting of HBsAg produced by a recombinant DNA in yeast cells or in 
continuous mammalian cell lines. The HBsAg expressed in yeast forms 
particles 15–30 nm in diameter, with the morphologic characteristics of free 
surface antigen in plasma though the polypeptide antigen produced by 
recombinant yeast is not glycosylated. The vaccine formulated using this 
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purified material has a potency similar to that of vaccine made from plasma-
derived antigen. 
Vaccination 
Hepatitis B vaccination is the most effective method in the prevention of 
HBV and its consequences. Hepatitis B vaccine currently is recommended by 
the WHO, CDC (Centre’s for Disease Control and Prevention), and the 
Advisory Committee on Immunization Practices for all susceptible, at-risk 
groups. It involves universal vaccination of infants, routine screening of all 
pregnant women for HBsAg, post exposure immune prophylaxis of infants born 
to HBsAg-positive mothers, vaccination of children and adolescents not 
previously vaccinated, and vaccination of unvaccinated adults at increased risk 
of infection like commercial sex workers and trans genders. 
Response to vaccination in Immunosuppressed groups, like HIV infected, 
patients on chemotherapy and haemodialysis patients less compared to healthy 
individuals. 
Passive immunization with hepatitis B immune globulin (HBIG) is 
effective when given soon after exposure. Persons exposed to HBV 
percutaneous route or by contamination of mucosal surfaces should 
immediately receive both HBIG and HBsAg vaccine administered 
simultaneously at different sites to provide immediate protection with passively 
acquired antibody followed by active immunity generated by the vaccine. 
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Pregnant women with type B hepatitis can transmit the disease to their 
infants. The efficiency of hepatitis vaccine and HBIG in averting hepatitis B 
infection in infants born to HBV-positive mothers is well documented.  
The spouses and intimate contacts of persons with acute type B hepatitis 
are at increased risk of obtaining clinical type B hepatitis so it is essential to 
inform that these practices might increase the risk of infection or transmission 
which makes councilling for these patients and vaccination for the high risk 
groups is important in curtailing the disease. 
HEPATITIS C VIRUS 
Worldwide there are more than 170 million chronic carriers who are at 
risk of developing liver cirrhosis and liver cancer. In 1997 the WHO has 
estimated that about 3% of the world population has been infected with 
Hepatitis C virus infection, with high prevalence rates of 10% in Africa 
followed by South America and Asia.  
STRUCTURE: 
Hepatitis C virus belonging to family Flaviviridae and genusHepacivirus 
is a positive-stranded RNA virus. Various viruses can be differentiated by RNA 
sequence analysis into at least six major genotypes (clades) and more than 100 
subtypes. The genome is 9.4 kb in size and encodes a core protein, two 
envelope glycoproteins, and several non-structural proteins.  
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HCV exhibits genomic diversity, with different genotypes (clades) 
predominating in different parts of the world. During chronic infections the 
virus undergoes sequence variation. This complex viral population in a host is 
referred to as "quasi-species." This genetic diversity is not correlated with 
differences in clinical disease, although differences do exist in response to 
antiviral therapy according to viral genotype.  
Routes of transmission 
HCV is transmitted mainly by direct percutaneous exposures to blood, 
though in 10–50% of cases the cause of HCV cannot be identified. In 
approximately decreasing order of prevalence of infection are IV drug users 
(about 80%), haemophiliacs treated with clotting factor products, recipients of 
transfusions from HCV-positive donors, chronic haemodialysis patients (10%), 
persons who engage in high-risk sexual practices, and health care workers (1%). 
Estimates of vertical transmission of mother-to-child vary from 3% to 10%. 
HCV infection has been associated with tattooing. Mothers with higher HCV 
viral loads or coinfected with HIV more frequently transmit HCV. No risk of 
transmission has been associated with breast feeding. 
INCUBATION PERIOD 
The average incubation period for HCV is 6–7 weeks. The average time 
from exposure to seroconversion is 8–9 weeks, and about 90% of patients are 
anti-HCV-positive within 5 months.  
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CLINICAL FINDINGS 
Most primary infections are clinically mild in which 20–30% have 
jaundice, 10–20% have only nonspecific symptoms such as anorexia, malaise, 
and abdominal pain. Most of the times the new infections with HCV are 
subclinical. The majority (70–90%) of HCV patients develop chronic hepatitis, 
and many are at risk of progressing to chronic active hepatitis and cirrhosis (10–
20%). Diseases related with chronic HCV infections include mixed 
cryoglobulinemia and glomerulonephritis. 
Laboratory diagnosis 
Serologic assays are available for diagnosis of HCV infection. Enzyme 
immunoassays (EIA) detect antibodies to HCV but do not distinguish between 
acute, chronic, or resolved infection. Anti-HCV antibodies can be detected in 
50–70% of patients at onset of symptoms, whereas in others antibody 
appearance is delayed 3–6 weeks. Antibodies are directed against core, 
envelope, and NS3 and NS4 proteins and tend to be relatively low in titer. 
Nucleic acid-based assays (PCR, RT-PCR) can genotype the HCV isolates and 
detect the presence of circulating HCV RNA and are beneficial for monitoring 
patients on antiviral therapy. 
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 Prevention and control 
Even though several candidate vaccines are under research currently there 
is no vaccine for hepatitis C .Control measures emphasis on prevention 
activities that reduce risks for contracting HCV which are screening and testing 
blood, plasma, organ, tissue, and semen donors; virus inactivation of plasma-
derived products; counselling of persons with high-risk drug or sexual practices; 
implementation of infection control practices in health care and other settings; 
and professional and public education. 
BACTERIAL CAUSES OF STI 
NEISSERIA GONORRHOEAE 
Neisseria gonorrhoeae infection one of the commonest STIs worldwide in 
distribution which is estimated to be about 106.1 million new cases worldwide.           
Gonorrhoea is exclusively transmitted by sexual contact, often by women and 
men with asymptomatic infections. The infectivity of the organism is such that 
the chance of acquiring infection from a single exposure to an infected sexual 
partner is 20–30% for men and even greater for women. The infection rate can 
be reduced by avoiding multiple sexual partners, rapidly eradicating gonococci 
from infected individuals by means of early diagnosis and treatment, and 
finding cases and contacts through education and screening of populations at 
high risk. Mechanical prophylaxis (condoms) provides partial protection. 
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Chemoprophylaxis is of limited value because of the rise in antibiotic resistance 
of the gonococcus. 
Neisseria gonorrhoeae 
Gonococci is a gram negative intracellular diplococci which ferments 
only glucose and differ antigenically from the other neisseriae.  
Antigenic Structure 
N gonorrhoeae is antigenically heterogeneous and capable of changing its 
surface structures in vitro—and presumably in vivo—to avoid host defenses. 
Surface structures include the following. 
Pili (Fimbriae) 
Pili are the hair-like appendages that extends from the surface of the 
organisms which improves the attachment to host cells and resistance to 
phagocytosis. Mostly all the strains of N gonorrhoeae will be having 
antigenically different pillins. 
Por 
Por protein extends through the gonococcal cell membrane.Por proteins 
are having important impact intracellular killing of gonococci within 
neutrophils by preventing phagosome-lysosome fusion.  
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Opa Proteins 
Opa proteins plays important role in attachment of gonococci to host cells 
and attachment of gonococci within colonies  
Lipooligosaccharide (LOS) 
Gonococci can express more than one antigenically different LOS chain 
simultaneously. Toxic nature of the gonococcal infections is mainly due to the 
endotoxic effects of LOS. 
The sialyation of terminal galactose of human glycosphingolipids with 
sialic acid makes the organism resistant to killing by the human antibody-
complement system and interferes phagocytic cells binding to the organism. 
Antibiotic resistance 
Gonococci has many plasmids of which 95% of strains have a small, 
"cryptic" plasmid of unknown function. Two other plasmids (MW 3.4 x 10
6
 and 
4.7 x 10
6
) comprises genes coding for β-lactamase production making them 
resistant to penicillin which could be acquired from Haemophilus or other 
gram-negative organisms. They are transmissible by conjugation among 
gonococci. Insertion of a streptococcal gene tetM coding for tetracycline 
resistance into the conjugative plasmid has brought the high-level tetracycline 
resistance in gonococci. 
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PATHOGENESIS 
Mucous membranes of the genitourinary tract, eye, rectum, and throat are 
the targets of gonococci causing acute suppuration leading to tissue invasion 
followed by chronic inflammation and fibrosis.  
In males, mostly it causes urethritis and sometimes it can be 
asymptomatic. Urethritis causes yellow, creamy pus and painful urination. If 
untreated suppuration diminishes and fibrosis occurs, occasionally leading to 
urethral strictures.  
 In females, endocervix is site to get affected initially which then spreads 
to the urethra and vagina, giving rise to mucopurulent discharge. Infection in the 
fallopian tubes, causes salpingitis, fibrosis, and tubal obstruction causing 
infertility.  
 Gonococcal bacteremia leads to skin lesions of the hands, forearms, feet, 
and legs. Gonococcal tenosynovitis and suppurative arthritis, generally affects 
knees, ankles, and wrists. Gonococci can be cultured from blood or joint fluid of 
only 30% of patients with gonococcal arthritis.  
Gonococcal endocarditis is a rare yet severe infection. Gonococcal 
bacteremia is seen frequently in complement deficiency. Gonococcal 
ophthalmia neonatorum is acquired during passage through an infected birth 
canal. If untreated the conjunctivitis rapidly progresses to blindness. To prevent 
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gonococcal ophthalmia neonatorum can be prevented by instillation of 
tetracycline, erythromycin, or silver nitrate. 
Diagnostic Laboratory Tests 
Specimens 
Pus and secretions are taken from the urethra, cervix, rectum, 
conjunctiva, throat, or synovial fluid for culture and smear.  
Smears 
Gram-stained smears of endocervical or urethral exudate shows many 
intracellular gram negative diplococci within pus cells. These give a 
presumptive diagnosis. Stained smears of the urethral exudate from men have a 
sensitivity of about 90% and a specificity of 99%.  
Stained smears of endocervical exudates have a sensitivity of about 50% 
and a specificity of about 95%. Cultures of urethral exudate from men are not 
necessary when the stain is positive, but cultures should be done for women. 
Stained smears of conjunctival exudates can also be diagnostic, but those of 
specimens from the throat or rectum are generally not helpful. 
Culture 
Immediately after collection, pus or mucus is streaked on modified 
Thayer-Martin medium (has antibiotics like Vancomycin, 3µg/mL; Colistin,  
7.5 µg/mL; Amphotericin B, 1µg/mL; and Trimethoprim, 3µg/mL) and 
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incubated in 5% CO2(candle jar) at 37 °C. If immediate incubation is not 
possible, the specimen should be placed in a CO2-containing transport-culture 
system. Forty-eight hours after culture, the organisms can be quickly identified 
by their appearance on a Gram-stained smear, by oxidase positivity, and by 
coagglutination, immunofluorescence staining, or other laboratory tests. The 
species of sub cultured bacteria may be determined by fermentation reactions 
RCUT (rapid carbohydrate utilisation test). 
Gonococci generally produce smaller colonies than those of the other 
neisseriae. Gonococci that require arginine, hypoxanthine, and uracil tend to 
grow most slowly on primary culture. Gonococci isolated from clinical 
specimens or maintained by selective subculture like modified Thayer Mayer 
medium will have typical small colonies containing piliated bacteria. On 
nonselective subculture as in chocolate culture larger colonies containing 
nonpiliated gonococci are formed. Opaque and transparent variants of both the 
small and large colony types also occur. 
Nucleic Acid Amplification Tests 
Several FDA-cleared nucleic acid amplification assays are available for 
direct detection of N gonorrhoeae in genitourinary specimens. Nucleic Acid 
Amplification Tests have excellent sensitivity and specificity in symptomatic, 
high-prevalence populations. Advantages of these Nucleic Acid Amplification 
Tests is better detection, more rapid results, and the ability to use urine as a 
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specimen source. Disadvantages include poor specificity of some assays due to 
cross reactivity with nongonococcalNeisseria species. These tests are not 
suggested for use for the diagnosis of extragenitalgonococcal infections. 
Serology 
Serum and genital fluid contain IgG and IgA antibodies against 
gonococcal pili, outer membrane proteins, and LPS. Some IgM of human sera is 
bactericidal for gonococci in vitro.These antibodies can be detected by 
immunoblotting, radioimmunoassay, and ELISA tests. But theseassays are not 
useful as diagnostic aids for many reasons like gonococcal antigenic 
heterogeneity, the delayed antibody development in acute infection; and a high 
background level of antibodies in the sexually active population. 
Immunity 
Repeated gonococcal infections are common. Protective immunity to 
reinfection does not appear because ofgonococcal antigenic heterogeneity. 
Antibodies like IgA and IgG can be demonstratedon the mucosal surfaces, they 
either are highly strain-specific or have little protective ability. 
Treatment 
Development and the widespread use of penicillinhas increased the 
gonococcal resistance to penicillin so that many strains now require high 
concentrations of penicillin G for inhibition. Penicillinase-producing N 
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gonorrhoeae (PPNG) also have increased in prevalence. High-level resistance 
to tetracycline also occurring due to chromosomally mediated resistance to 
tetracycline. Spectinomycin resistance and fluoroquinolones resistance has been 
noted. 
Gonococcalophthalmianeonatorum is prevented by local application of 
0.5% erythromycin ophthalmic ointment or 1% tetracycline ointment to the 
conjunctiva of newborns. As silver nitrate solution is difficult to store and can 
causes conjunctival irritationit has mostly been substituted by use of 
erythromycin or tetracycline ointment. 
 As the problems with antimicrobial resistance in N gonorrhoeae, the US 
Public Health Service recommends that uncomplicated genital or rectal 
infections be treated with ceftriaxone given intramuscularly as a single dose.  
TREPONEMAPALLIDUM 
STRUCTURE 
Treponemapallidum is an actively motile slender spirals rotating steadily 
around their endoflagella measuring about 0.2 µm in width and 5–15 µm in 
length. The spiral coils are regularly spaced at a distance of 1 µm from one 
another. The long axis of the spiral is usually straight but may occasionally 
bend, so that the organism forms a complete circle sometimes and returningback 
to its normal straight position. 
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The spirals are so thin that they are not easily seen unless 
immunofluorescent stain or dark field illumination is used.it can be visualised 
by staining with silver impregnation method. 
Genome 
The T pallidum genome is a circular chromosome of about 1138kbp 
which is small when compared with other bacteria and also they don’t have 
transposable elements, which makes their genome highly conserved and that 
explains its constant susceptibility to penicillin. There are only few genes 
involved in energy production and synthesis of nutrients, which makes T 
pallidum to obtain these from the host. 
Antigenic Structure 
Since T pallidum cannot be cultured in vitro the characterization of its 
antigens is limited. The outer membrane surrounds the periplasmic space which 
has the endoflagella and the peptidoglycan-cytoplasmic membrane complex. 
The lipids seems to bind the proteins to the cytoplasmic or outer membranes 
and keep the proteins unreachable to antibodies. 
 The endoflagella are composed of three core proteins similar to other 
bacterial flagellin proteins, plus an unrelated sheath protein. T pallidum 
subspecies pallidumhas an enzyme hyaluronidase whichdisruptions the 
hyaluronic acid in the ground substance of tissue responsible for the 
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invasiveness of the organism. Approximately more than 100 protein antigens 
have been recognised. The protein profiles of T pallidum (all the subspecies) are 
indistinguishable; Cardiolipin is an important component of the treponemal 
antigens. 
Culture 
Pathogenic T pallidum has never been cultured continuously on any 
artificial media. Only the non-pathogenic treponemes Reiter strain, can be 
cultured anaerobically in vitro.  
Growth Characteristics 
T pallidum is a microaerophilic organism which survives best in the 
environment containing 1–4% oxygen. The non-pathogenic treponemes Reiter 
strain grows on a well-defined medium of 11 amino acids, vitamins, 
minerals,albumin, salts, and serum. 
When kept in proper suspending fluids and reducing substances, T 
pallidum may remain motile for 3–6 days at 25 °C. In whole blood or plasma 
stored the organisms remains viable for at least 24 hours when stored at 4 °C, 
which is of potential importance in blood transfusions. 
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Pathogenesis, Pathology, & Clinical Findings 
Acquired Syphilis 
Natural infection with T pallidum is restricted to the human host and 
transmitted by sexual contact. The infectious lesion is on the skin or genital 
mucous membranes. However in 10–20% of cases, the primary lesion is 
intrarectal, perianal, or oral. It can penetrate intact mucous membranes and even 
it can enter through a break in the epidermis. 
T pallidum multiply locally at the entry site, and spread to nearby lymph 
nodes and then reach the bloodstream. In 2–10 weeks after infection, a papule 
develops at the site of infection and breaks down to form an ulcer with a clean, 
hard base which is called the "hard chancre". The inflammation is characterized 
by abundant of lymphocytes and plasma cells. This "primary lesion" always 
heals spontaneously, but 2–10 weeks later the "secondary" lesions appear. 
Secondary lesions consist of a red maculopapular rash anywhere on the body, 
including the hands and feet, and moist,condylomas in the anogenital region, 
mouth and axilla. Complications like syphilitic meningitis, chorioretinitis, 
hepatitis, nephritis, or periostitis also occurs. The secondary lesions also recede 
spontaneously. Both primary and secondary lesions are highly infectious and 
rich in spirochetes. Contagious lesions may reappear within 3–5 years after 
infection, but after that the individual is not infectious. T pallidum infection may 
remain subclinical, and the patient may go through the primary or secondary 
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stage or even both without any symptoms or signs and may develop to tertiary 
lesions. 
Early syphilitic infection progresses spontaneously to complete cure 
without treatment in about 30% of cases. In another 30%, the infection remains 
latent (known only by positive serologic tests). In the remaining, the disease 
progresses to the "tertiary stage," characterized by the development of gummas 
in skin, bones, and liver and degenerative changes involving the central nervous 
system (meningovascular syphilis, paresis, tabes) and cardiovascular system 
(aortitis, aortic aneurysm, aortic valve insufficiency). In all tertiary lesions, 
finding treponemes are very rare, and the exaggerated tissue response must be 
attributed to hypersensitivity to the organisms. Though, the treponemes can 
rarely be seen in the eye or central nervous system in late syphilis. 
Congenital Syphilis 
Vertical transmission from the pregnant syphilitic mother to the foetus 
through the placenta happens in the 10th to 15th weeks of gestation. Some of 
the infected foetuses die resulting in miscarriages; others are stillborn at term. 
The infected foetuses born lives but develop the signs of congenital syphilis in 
childhood like interstitial keratitis, Hutchinson's teeth, saddle nose, periostitis, 
and a range of central nervous system anomalies. Proper treatment of the mother 
during pregnancy prevents congenital syphilis.  
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Diagnostic Laboratory Tests 
Demonstration of antibodies against T pallidum by indirect 
immunofluorescence, immobilizing and killing live motile T pallidum and 
fixing complement in the presence of a suspension of T pallidum or related 
spirochetes is the diagnostic tests available. Reagin is a mixture of IgM and IgG 
antibodies directed against the cardiolipin-cholesterol-lecithin complex 
andgives positive complement fixation and flocculation tests with aqueous 
suspensions of cardiolipin extracted from normal mammalian tissues. Both 
reagin and antitreponemal antibody are used for the serologic tests of syphilis. 
Specimens 
Specimens include tissue fluid expressed from early skin/mucosal surface 
lesions for demonstration of spirochetes; blood serum for serologic tests. 
Darkfield Examination 
A drop of tissue fluid or exudate is placed on a slide and a cover slip 
pressed over it to make a thin layer and examined under oil immersion with 
dark field illumination for motile spirochetes.  
Immunofluorescence 
The tissue fluid or exudate is spread on a glass slide, air dried, fixed, 
stained with a fluorescein-labelled antitreponeme serum, and examined with 
immunofluorescence microscopy for typical fluorescent spirochetes. 
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Serologic Tests for Syphilis (STS) 
These tests use either nontreponemal or treponemal antigens. 
Nontreponemal Antigen Tests 
The antigens used in these tests are lipids extracted from normal 
mammalian tissue. The purified cardiolipin from beef heart is a 
diphosphatidylglycerol. Lecithin and cholesterol are added to increase reaction 
with syphilitic "reagin" antibodies. The VDRL (Venereal Disease Research 
Laboratory) and RPR (rapid plasma reagin) tests are nontreponemal antigen 
tests used most generally. The toluidine red unheated serum test (TRUST) also 
is available. All of the tests are based on the fact that the particles of the lipid 
antigen remain spread with normal serum but flocculate when combining with 
reagin.  
The VDRL flocculation testrequires microscope for detection, whereas 
the RPR and TRUST have the colored particles like carbon and can be read with 
naked eye. Results develop within a few minutes, particularly if the suspension 
is agitated. 
Positive VDRL or RPR tests becomes positive after 2–3 weeks of infection and 
are positive in high titer in secondary syphilis. Positive VDRL or RPR tests 
return to negative in 6–18 months after effective treatment of syphilis. The 
VDRL test can done in cerebrospinal fluid and becomes positive after 4–8 
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weeks of infection. Even though the reagin antibodies do not cross blood brain 
barrier and reach the cerebrospinal fluid from the bloodstream but are perhaps 
formed in the central nervous system in response to syphilitic infection. 
The flocculation tests can give quantitative results by estimating of the 
amount of reagin present in serum with twofold dilutions of serum and 
expressing the titer as the highest dilution that gives a positive result. 
Quantitative results are valuable in establishing a diagnosis especially in 
neonates and in monitoring the effect of treatment. 
Nontreponemal tests can give biological false-positive results due to the 
occurrence of reagin antibody in many human disorders. Important among them 
are malaria, leprosy, measles, infectious mononucleosis, vaccinations,systemic 
lupus erythematosus, polyarteritis nodosa, rheumatic disorders and other 
conditions. 
Treponemal Antibody Tests 
Fluorescent Treponemal Antibody (FTA-ABS) Test 
It is an indirect immunofluorescence in which the killed T pallidum, 
patient's serum and labelled antihuman gamma globulin are used. FTA-ABS has 
good specificity and sensitivity for syphilis antibodies if the patient's serum has 
been absorbed with sonicated Reiter spirochetes prior to the FTA test. The 
FTA-ABS test is the first to become positive in early syphilis, is usually positive 
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in secondary syphilis. This test usually remains positive many years after 
effective treatment making it unable to judge the efficacy of treatment. The 
presence of IgM FTA in the blood of new-borns is good evidence of in 
congenital syphilis. 
Treponemapallidum-Particle Agglutination (TP-PA) Test 
These are the T pallidumhemagglutination (TPHA) and 
microhemagglutination for T pallidum (MHA-TP) tests similar to the FTA-
ABS test in specificity and sensitivity. Particles are sensitized with T pallidum 
subspecies pallidum antigens. The test is performed with diluted serum. 
Antibodies against T pallidum react with the sensitized particles. A mat of 
agglutinated particles indicates a positive result. 
Immunity 
A person with active or latent syphilis or yaws seems to be resistant to 
superinfection with T pallidum.Conversely, if early syphilis or yaws is treated 
effectively and the infection is eradicated, the patient again becomes completely 
susceptible.  
Treatment 
Penicillin is the treatment of choice. Penicillin in concentrations of    
0.003 unit/mL has definite treponemicidal activity. Single injection of 
benzathine penicillin G intramuscularly can treat Syphilis of less than 1 year 
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duration. If a person is allergic to penicillin then other antibiotics like 
tetracyclines and erythromycin can be substituted. A typical Jarisch-Herxheimer 
reaction may occur within hours after treatment is begun which is due to the 
release of toxic products from dying or killed spirochetes. 
 BACTERIAL VAGINOSIS 
Previously known as non-specific vaginitis, anaerobicvaginosis, 
Gardernerella vaginosis or haemophilus vaginalis vaginitis but later after 1983 
the term bacterial vaginosis become popular as this condition is a combination 
of overgrowth of certain bacteria and the absence of inflammatory response. It 
is the commonest cause of vaginal discharge of women of child bearing age 
group.it is a clinical syndrome with the symptoms of increased vaginal 
discharge with foul smelling fishy odour which is more offensive after sexual 
intercourse 
ETIOLOGICAL AGENTS 
Gardernerella vaginalis, Prevotella spp.,Peptostreptococci,Mobiluncus 
spp., like Mobilun cuscurtisii which are small curved  gram variable organisms 
and Mobiluncus mulieris  which is long curved ,gram negative organisms and 
Mycoplasma hominis are closely associated with  bacterial 
vaginosis.Eventhough these organisms are found in normal vagina but in BV 
these organisms will increase 100-1000 fold
21
. 
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Pathology 
The organisms will adhere to the squamous epithelial cells and will give 
them studded appearance .this type of studded epithelial cell is called as ‘clue 
cells. These organisms produce amines which increases the vaginal pH from 
from 4.5 to 5.0 or greater. 
Predisposing factors 
Its prevalence is more among the sexually active women attending the STD 
clinics and women using intrauterine devices
21
. 
Diagnosis: 
The accepted standard for the diagnosis of BV has been the Amsels 
criteria which include thin homogenous vaginal discharge, elevated vaginal pH, 
presence of amines detected by fishy odour after the addition of KOH to the 
discharge and the presence of clue cells. Since in this method vaginal 
examination is needed and fishy odour is a subjective feature. 
Alternative to this method is the Nugent’s scoring in which the grading or 
scoring of the gram stained vaginal smear to detect the changes in vaginal 
ecology .Quantification of the number of different type bacteria like lactobacilli, 
Gardernerella ,Bacteroides and mobiluncus  is done and the score for each of 
these is combined and grading is done.  
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TREATMENT  
Metronidazole is the drug of choice is 400mg for 5 days and the partner 
will have to be treated simultaneously. Topical clindamycin 2% has been also 
used twice daily for 7 days. 
SEQUELAE 
Women with BV who are pregnant have increased the risk of late 
miscarriage and preterm birth. 
PARASITIC CAUSES OF STI 
TRICHOMONIASIS 
T vaginalis is a common parasite of both males and females. Infection 
rates vary greatly but may be quite high (40% or higher). Transmission is by 
sexual intercourse, but contaminated towels, examination instruments, and other 
objects acts as fomites and may be responsible for some new infections. Infants 
may be infected during birth.  
STRUCTURE 
T vaginalis is pear-shaped, with a short undulating membrane lined with a 
flagellum and four anterior flagella. It measures about 10 x 7 µm, though its 
length may vary from 5 to 30 µm and its width from 2 to 14 µm. The organism 
moves with a characteristic wobbling and rotating motion. The non-pathogenic 
trichomonads like Trichomonashominis and Trichomonastenax, cannot readily 
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be distinguished from T vaginalis when alive. For all practical purposes, 
trichomonads found in the mouth are T tenax; in the intestine, T hominis; and in 
the genitourinary tract (both sexes)T vaginalis. 
Pathogenesis, Pathology, & Clinical Findings 
In females, the infection is normally limited to vulva, vagina, and cervix; 
it does not usually extend to the uterus. The mucosal surfaces may be tender, 
inflamed, eroded, and covered with a frothy yellow or cream-colored discharge.  
In males, the prostate, seminal vesicles, and urethra may be infected. 
Signs and symptoms in females, in addition to profuse vaginal discharge, 
include local tenderness, vulval pruritus, and burning. About 10% of infected 
males have a thin, white urethral discharge. 
Diagnostic Laboratory Tests 
Specimens and Microscopic Examination 
Wet mount of vaginal or urethral secretions or discharge shows characteristic 
motile trichomonads. Dried smears may be stained with Giemsa or other stains. 
Culture 
Trichomonas Modified CPLM Medium Base with addition of horse 
serum and antibiotics is recommended for cultivation of Trichomonas species. It 
contains L-Cysteine, Pepticdigest, liver digest and maltose with antibiotics like 
penicillin, streptomycin and antifungals Nystatin.Culture of vaginal or urethral 
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discharge, of prostatic secretion, or of a semen specimen may reveal organisms 
when direct examination is negative. Simplified trypticase serum is usually used 
for semen cultures. T vaginalis grows best at 35–37 °C under anaerobic 
conditions, less well aerobically. The optimal pH for growth in vitro (5.5–6.0) 
suggests why vaginal Trichomoniasis is more severe in women with higher than 
normal vaginal pH 
Treatment 
Successful treatment of vaginal infection requires destruction of the 
trichomonads, for which topical and systemic metronidazole is best. Partner 
treatment is also important in complete treatment regimen. Condoms should be 
used during intercourse until the infection is eradicated in both partners. 
FUNGAL CAUSES OF SEXUALLY TRANSMITTED INFECTIONS. 
CANDIDIASIS 
Candidal vulvovaginitis is believed to be the most frequent or second most 
frequent cause of vaginal infection, depending upon the geographical area and 
its incidence is estimated in the range of 5 to 20 percent
21
. 
 The first known description of candida infection, oral candidiasis 
(Thrush) in two patients with other underlying disease, may be found in 
Hippocrates ‘Epidemics’ from the fourth century BC.Even though the existence 
of candidiasis from very beginning two major medical events had increased the 
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interest in the fungal diseases particularly candida infections. The first was the 
introduction of broad spectrum antibiotics which caused the imbalance of hosts 
normal flora in favour of fungi upon which these antibiotics have no action and 
the another one is the increased prevalence of immunosuppressed patients due 
to chemotherapy and diseases like AIDS  in the recent few decades both of 
these events had increased the incidence of candida infection in general and also 
the non C.albicans
21
 .Along with these the increased use of broad spectrum 
antifungals like azoles had changed the decreased prevalence of C.albicans as 
the etiological agent of candidiasis and increased the proportion of non-albicans 
species such as C.glabrata or C.krusei 
ETIOLOGICAL AGENT 
The genus candida includes about 200 species out of which about 20 have 
been associated with infections in humans and animals. The main pathogenic 
organism is the candida albicans and the candida non albicans like candida 
glabrata, candida tropicalis, candida krusei, candida parapsilosis and candida 
dubliniensis. 
CLINICAL FEATURES 
Vulvovaginal candidiasis includes the symptoms of Vulvovaginal pruritis 
and vaginal discharge which is thick and curd like. Erythema of the 
Vulvovaginal mucosa is also seen.in males candidiasis manifests as balanitis 
and erythema on the penis. 
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LABORATORY DIAGNOSIS 
DIRECT EXAMINATION 
Specimen from oral and fungal candidiasis is taken by swab and the specimen is 
need not to be treated with keratinolytic agents. Both the wet mount and gram, 
methylene blue or Giemsa stain can be done. 
Microscopic examination of specimens reveals presence of budding yeast 
cells, pseudohyphae and /or hyphae. The demonstration of hyphal elements in 
clinical specimens is important as it is a indicator of infection since the mouth 
and vagina can be normally colonised by candida spp., however another fact 
also to be taken in consideration is that candida glabrata, a important non 
albicans species of vaginal candidiasis does not produce any hyphae or 
pseudohyphae in clinical specimens. 
CULTURE 
Sabourauds dextrose agar supplemented with antibiotics like 
chloramphenicol, Gentamicin and /or Tetracycline to prevent the bacterial 
overgrowth and incubated at28
0
C or/and at 37
0
C the colonies will be apparent 
within 24hrs or up to 3 days maximum. 
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Germ tube test 
The ability of C.albicans or C.dubliniensisblastospores to produce germ 
tubes in serum incubated at 37
0
C for 2 hours offers a reliable and easy method 
of identification. 
Speciation of Candida 
The macroscopic appearances of the colonies of candida and non albicans 
are almost similar with only few differences like in candida krusei the colonies 
will be more dry creamy colonies compared to candida albicans which have 
creamy pasty colonies but these are difficult to interpret and have subjective 
variation. 
CHROMagar system 
This method uses principle that reaction between the specific enzymes of 
the different species and chromogenic substances present in the culture medium 
will produce the differently coloured colonies. 
PHYSIOLOGICAL AND BIOCHEMICAL CHARACTERISATION 
Tests based on the pattern of utilisation of specific carbohydrate and 
nitrogen substances are used for speciation which includes Wicerham and 
Burton method and auxanographic technique and also by the commercial kits. 
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MOLECULAR METHODS 
The common molecular probes used for the molecular studies like PCR, 
restriction enzyme analysis and RNA profiling are ribosomal DNA primers 
including large and small rRNA subunits and ERG11 gene which is involved in 
ergosterol biosynthesis 
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MATERIALS AND 
METHODS 
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MATERIALS AND METHODS 
STUDY DESIGN 
  Prospective Study  
PLACE OF STUDY 
1. Department of Microbiology, Stanley medical College, Chennai. 
2. Department of Sexually Transmitted Diseases, Stanley medical College 
and Hospital, Chennai 
Study Period: 
September 2013 to September 2014. 
SAMPLE SIZE 
The sample size was determined using Open Epi Version 2.3.1 with a power of 
80% and confidence level of 0.05. The estimated sample size was 196 
considering the attrition rate 2 % a total sample of 200 was used for study 
enrollment.  
 INCLUSION CRITERIA 
1. Trans genders involved in the commercial sex works 
2. Male Homosexuals 
3. Commercial Sex workers 
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EXCLUSION CRITERIA 
1. Patients who are treated for any of the sexually transmitted infections with 
antibiotics. 
2. Women aged > 18 yrs attending STD clinic and from Referral Centres both 
symptomatic and asymptomatic 
3. Men aged >18 yrs attending STD clinic and from Referral Centres both 
symptomatic and asymptomatic 
4. Unmarried women, pregnant women and Women with vaginal bleeding 
Ethical Consideration 
Ethical and research clearance was obtained from the Ethical committee 
Stanley Medical College. Permission to conduct the study was sought from the 
respective hospital department authorities. Informed consent was obtained from 
the patients before enrolment in to the study. 
Statistical Analysis 
The collected data was analyzed with SPSS 16.0 version. To describe 
about the data descriptive statistics frequency analysis, percentage analysis were 
used for categorical variables and for continuous variables the mean and S.D 
were used. Receiver operating characteristic (ROC) curves were drawn to find 
out area under the curve (AUC) so as to achieve the highest average sensitivity 
and specificity. To find the significance in categorical data Chi-Square test was 
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used. In both the above statistical tools the probability value .05 is considered as 
significant level 
SPECIMEN COLLECTION:  
Method of collection of specimen: 
1) Urethral swab 
22, 23
: 
The specimen was collected after wearing sterile gloves and 1 hour after 
the patient has urinated. After retracting the prepuce, tip of the meatus was 
cleaned with normal saline and if purulent discharge (pus) from urethra was 
seen, it was collected using a sterile cotton wool swab or loop. If no discharge 
was seen, milking of the urethra was done towards the orifice to obtain the 
discharge. Six swabs were taken – one for gram stain, one for direct plating into 
Modified Thayer Martin medium &chocolate agar for gonococcus culture, one 
for inoculation into Sabourads dextrose agar for Candida culture, one for wet 
mount & one for inoculation into Diamonds medium for Trichomonas vaginalis 
culture and one swab placed in 70% ethanol test tube for viral isolation. If 
discharge was not seen even after milking, a sterile thin cotton wool swab 
inserted 2-3 cms into the urethra and rotated for 5-10 seconds to gently scrap the 
mucosa and then inoculated into Chocolate agar & Modified Thayer Martin 
medium for gonococcus culture. 
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THROAT SWAB 
COLLECTION AND TRANSPORT OF THROAT SWABS
25 
It was made sure that the patient was not treated with antibiotics or 
antiseptic mouth-washes (gargles) 8 hours before swabbing.  
1. In a good light and using the handle of a tongue depressor the tongue was 
depressed and inside of the mouth was examined. Any inflammation, 
membrane, exudate, or pus are noted  
2. Swabbing done in the tonsils, tonsillar crypts, peritonsillar area and posterior 
pharyngeal wall using a sterile cotton wool swab. Swab was taken without 
contaminating the swab with saliva and placed in the sterile test tube. 
Four swabs were taken – one for gram stain, one for direct plating into Modified 
Thayer Martin medium & chocolate agar for gonococcal culture and one swab 
placed in 70% ethanol test tube for viral isolation. 
Collection of cervical specimens from female patients 
Sterile vaginal speculum was used to examine the cervix and the specimen was 
collected. 
 Speculum was moistened with sterile warm water instead of lubricating 
gel as it may be bactericidal, and inserted into the vagina. Cervix was cleaned 
using a swab moistened with sterile physiological saline a sterile Dacron swab 
is passed  20–30 mm into the endocervical canal and gently rotated against the 
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endocervical wall to obtain a specimen. Four swabs were taken – one for gram 
stain, one for direct plating into Modified Thayer Martin medium & chocolate 
agar for gonococcus culture and one swab placed in 70% ethanol test tube for 
viral isolation. 
Collection of vaginal discharge  
Wet mount to detect motile T. vaginalis: 
 Using a sterile Dacron swab specimen is collected from the vagina. And 
the sample of the exudate is transferred in to a microscope slide to which a drop 
of normal saline is added and mixed and then covered with a cover glass.  
Direct smear for Gram staining to detect Candida and examine for clue 
cells 
 Using a sterile Dacron swab specimen was collected from the vagina. 
Sample of the exudate is transferred to a microscope slide and then spreaded to 
make a thinsmear. Smear was air dried and heat fixed for gram staining. 
Rectal swabs: 
 Specimen was collected using a sterile cotton wool swab. After the 
application of proctoscope moist Swab was inserted in to the rectum for about 2 
to 4 cm .swabs taken avoiding unnecessary contamination of the specimen with 
bacteria from the anal skin. Swabs with heavy faecal contamination is 
discarded. Four swabs were taken – one for gram stain, one for direct plating 
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into Modified Thayer Martin medium & chocolate agar for gonococcus culture 
and one swab placed in 70% ethanol test tube for viral isolation. 
3) Blood: 
 5 ml of blood collected from each patient and serum was separated either 
by keeping the sample containing test tube in 45° slanting position in 
refrigerator at 4-8°C for 4-6 hours or by centrifuging at 1500 rpm for 5-10 min. 
Serum was stored in sterile container at -20°C.Then the serum was tested for 
HIV as per NACO guidelines
23
, RPR for Syphilis, IgM and IgG antibody Elisa 
for Herpes Simplex virus 2, Rapid card test for Hepatitis B & C. 
SPECIMEN PROCESSING: IDENTIFICATION OF ORGANISMS 
1) Neisseria gonorrhoeae- 
a) Microscopy 
 With one swab, on a clean grease free slide, smear was prepared by 
rolling the swab in single direction. One directional smearing technique 
minimizes distortion and breakage of Polymorphonuclear leukocytes (PMNL) 
and thereby preserves the characteristic intracellular appearance of this 
microorganism. The smear was air dried and methanol fixed. Gram stain was 
done using saffranin as counterstain and examined under light microscope after 
putting a drop of cedar wood oil on the slide. 
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Reading: 
 The smear was examined for epithelial cells, Polymorphonuclear 
leucocytes (pus cells), organisms and their location whether extracellular or 
intracellular. The gonococci are intracellular; bean shaped and are usually 
arranged in pairs, 0.8µm x 0.6µm in size. They are Gram negative in reaction 
and are stained pink along with the nuclei and protoplasm of pus cells. The slide 
was examined for at least 2 minutes before declaring as negative for gonococci. 
b) CULTIVATION: 
 For inoculation of Neisseria gonorrhoeae culture, specimen were usually 
collected with Dacron or rayon swabs. Since calcium alginate or some cotton 
swabs may be toxic to Gonococci, they should be used only if the specimens 
were inoculated immediately into culture media. Media for isolation of 
Neisseria gonorrhoeae – Two types of media were used. One is non selective 
media like Chocolate agar. Other is selective media like modified Thayer 
Martin Medium with VCNT (Vancomycin-inhibit gram positive bacteria, 
Colistin-inhibit gram negative bacteria, Nystatin-inhibit yeasts and moulds, 
Trimethoprim inhibit swarming of Proteus) or Modified New York City 
Medium with VCNT . Media for isolation of Neisseria gonorrhoeae was kept at 
room temperature before inoculation and should not be excessively dry or 
moist. If excessive moisture present, plates are placed upside down in ajar in an 
incubator at 35°C for 20-30 minutes. 
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Method for inoculation: 
 The specimen was inoculated into the culture plate by rolling the swab on 
the surface of the plate in a “Z” pattern, then cross streaked with a sterile 
platinum/nichrome loop. The inoculated plates were kept in the upper part of 
candle jar after keeping the moist cotton ball/ wet paper towels inside the jar to 
provide >70% humidity and a lighted non colored candle in upright position in 
the lower part of the candle jar to provide 5% CO2.The lid of the jar was closed 
and the jar was kept in the incubator at 35 to 37°C after the candle was put off. 
The plates were examined after 18-24 hours and incubated for another 24 hours 
if there was no growth. The plates were examined after 48 hours. If no growth, 
reported as such. Small pin point, 0.5 to 1 mm in diameter, grey to white in 
color, smooth, translucent, raised convex colonies suggests Neisseria. 
Trichomonas vaginalis:  
a) MICROSCOPY 
 Adrop of discharge or urine sediment was put on a clean grease free 
microscope slide. One drop of normal saline was mixed with sediment and a 
coverslip was placed over it. The slide was observed first under 10 x 
magnification. Any field which shows the suspected organism is then seen 
under 40 x magnification of light microscope. 
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Reading: 
 Trichomonads are 15 µm in size, they have a pyriform shape with an 
anterior tuft of flagella and a lateral undulating membrane, the parasite moves 
actively, showing jerky motility, Centrifuged samples do not show motility 
because the flagella are detached during centrifugation. 
b) Staining: 
 On a clean grease free microscope slide smear was prepared from 
sediment. Then the smear was allowed to dry in air, fixed with methanol and 
stained with Giemsa stain. Stained smear was observed under oil immersion. 
c) Culture: 
 Culture is gold standard for the diagnosis of Trichomoniasis. The 
specimen was put in Diamond’s medium. The inoculum was placed at the 
bottom of the tube. The tube was incubated at 37º C. The culture was observed 
from second day onwards. The tubes were incubated for 7 days before declaring 
it as negative. For culture identification a wet mount was prepared from the 
culture and observed under microscope for the motile Trichomonas vaginalis. 
Candida species:  
a) Gram Staining: 
 A smear was prepared on a clean microscope slide and heat fixed. Then stained 
by Gram’s Method. Observed under oil immersion. 
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Reading:  
Gram positive budding yeast cells and pseudohyphae. 
b) Culture: 
 The sample was inoculated on two Sabouraud’s dextrose agar slopes. One 
slope was incubated at room temperature (25-27ºC). Pasty, opaque, cream 
colored colonies grow in 24-48 hours. The other slope was incubated at 37ºC 
gives faster growth. Grams stain showing the presence of budding yeast cells 
confirmed the diagnosis.  
c) Germ tube test:  
 Few colonies were inoculated into 0.5 ml of pooled human serum. 
Incubated at 37ºC for 2 hours in incubator. After 2 hours 2 drops of suspension 
was taken on a clean slide and mount with a coverslip. It was observed under  
40 x objective. Observation of germ tube confirms the presence of Candida 
albicans. A germ tube is a short, lateral  hyphal extension (filament) of the yeast 
cell and is not constricted at the base. 
d)SPECIATION 
Carbohydrate assimilation test:  
 A sterile Petri dish is taken and divided into four quadrants by marking 
the back of the plate with a glass marking pencil. About 4ml of Basal medium 
agar is melted and poured .About 2ml of pure yeast colonies suspension 
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(approx. 10
6  
colonies/ml) is prepared and each quadrant of the plate is labelled 
with the appropriate initial of the carbohydrate to be used. With the help of a 
sterile cotton wool swab the agar surface is inoculated with the yeast suspension 
and the appropriate carbohydrate solution is dropped on each quadrant with a 
separate dropper. The plate is incubated the plate at 25 – 30
0
C for 24 to 72 
hours. 
Reading: 
A growth ring of the yeast and a change in indicator color from purple to 
yellow – positive test. Carbohydrate is assimilated. 
No growth and no change in the indicator color – Negative test. The 
isolate lacks enzymes to assimilate that particular carbohydrate. 
Bacterial vaginosis 
 The collection of material for diagnosis is ideally performed during a 
comprehensive pelvic examination using a speculum. At the time of speculum 
examination, an evaluation of the nature of the discharge is made, specimen 
from the lateral vaginal wall and posterior fornix was taken with a sterile swab. 
 The classical BV discharge is thin, homogeneous and grey/yellow in 
color. However, absence of the classic discharge does not rule out disturbed 
vaginal flora. Two basic methods of diagnostic testing can be used: laboratory 
based and clinical 'bedside' testing. For the purposes of laboratory based testing, 
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the swab was rolled across a slide and the material allowed to air-dry. In the 
laboratory, the smear should be heat-fixed and Gram-stained. 
 In the methodology by Nugent et al
26
, the swab was obtained from the 
lateral vaginal wall and rolled on a glass slide. The smears were then heat fixed 
and Gram stained using safranin as the counterstain. The smear was then 
evaluated for the following morphotypes under oil immersion (1000x 
magnification): large Gram-positive rods (lactobacillus morphotypes), small 
Gram-variable rods (G vaginalismorphotypes), small Gram-negative rods 
(Bacteroides species morphotypes), curved Gram-variable rods (Mobiluncus 
species morphotypes) and Gram-positive cocci. Although Gram-positive cocci 
are not part of the scoring system, some laboratories will report them if they are 
present in significant numbers. Increased numbers of Gram-positive cocci are 
not part of the pattern of the normal vaginal flora. A score of zero to three is 
considered to be normal, four to six is considered intermediate and seven to ten 
is defined as Bacterial Vaginosis.  
 Intermediate vaginal flora is reported to the clinician for management 
based on the clinical context. Thirty two per cent of patients with an 
intermediate score will proceed to BV and 30% to normal flora. Even though 
clinical methodology is useful because it allows for an immediate answer in 
certain urgent clinical situations, but the Gram stain method appears to be more 
accurate.  
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NUGENT’S SCORING 
S.No Organism morphotypes Number/oil 
immersion field 
score 
1 Lactobacillis-like(parallel-sided, 
gram positive rods) 
>30 
5-30 
1-4 
<1 
0 
0 
1 
2 
3 
4 
 
2 Mobiluncus–like(curved, gram 
negative rods) 
>5 
1-4 
0 
2 
1 
0 
 
3 Gardernerella/bacteriods 
like(tiny,gramvariable 
coccobacilliandrounded 
,pleomorphic,gramnegative rods 
with vacuole) 
>30 
5-30 
1-4 
<1 
0 
4 
3 
2 
1 
0 
 
0-3 normal 
4-6 intermediate, test to be repeated later 
7-10 bacterial vaginosis 
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CULTIVATION 
Cultures for G. vaginalis should not be used to diagnose bacterial 
vaginosis because 36–55% of women without bacterial vaginosis will harbor 
this organism as part of normal flora. Although culture is not recommended for 
diagnosis of BV, the primary isolation of G. vaginalis from specimens 
containing mixed flora can be performed by using a selective, enriched human 
blood agar medium containing the antibiotics, colistin, and nalidixic acid.  
HBT (Human Blood Tween 80) Bilayer Medium was composed of a 
basal layer of 7 ml of CNA agar base, with amphotericinB (2pg/ml) added after 
autoclaving was performed, and a 14ml over layer of the same composition plus 
5% human blood and 0.0075% Tween 80 (BBL) was added to both layers after 
autoclaving was  performed. It is for the selective isolation and differentiation of 
Gardnerella vaginalis. Discharge taken from the vaginal discharge is swabbed in 
the plate and incubated anaerobically at 37
0
C in 5 to 10% Co2 for 72 hours as 
the 72 hours incubation increases the isolation rate of the organism
27
. The 
anaerobic environment will enhance the hemolytic property of the organism. 
The greyish white colonies surrounded by zones of diffuse hemolysis indicates 
growth. 
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Serological tests  
Immunochromatography Rapid test for HBsAg 
The HEPA™ Strip HBsAg test is a rapid, qualitative, one-step two-side 
sandwich immunoassay based on the immunochromatographic sandwich 
principle. The method employs a unique combination of monoclonal-dye 
conjugate (colloidal gold) and polyclonal solid phase antibodies to selectively 
identify Hepatitis B Surface antigen of Hepatitis B viral infection with a high 
degree of sensitivity. 
PROCEDURE: 
The specimen and Hepa™ Strip was brought to room temperature prior to 
testing. 4-6 drops of serum sample is added into the sample well avoiding 
overflowing and the reaction was proceeded until the appearance of positive line 
and control line.  
The result was red after 20 minutes. 
INTERPRETATION OF RESULTS: 
POSITIVE: Distinct purple line formed at the test zone marked 'T' (test line) 
and the control Zone marked 'C' (control line) the test result was positive,  
indicating that the sample contains Hepatitis B Antigen. 
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NEGATIVE: Distinct purple line formed only at the control zone marked 'C'  
                         (Control line) the test result was negative. 
ONE STEP ANTI HCV TEST 
SD BIO LINE HCV test is a immunochromatographic rapid test for the 
qualitative detection of antibodies specific to HCV in human serum, plasma or 
whole blood. It is a One-step qualitative immunochromatographic assay which 
uses the recombinant HCV Core, NS3, NS4, NS5 Ag used as capture materials  
Procedure 
10µl of serum sample is taken with a pipette and added to the well and 
then 4 drops of assay diluent provided with the kit is added to the well. The card 
was red after 20 minutes. 
 INTERPRETATION OF RESULTS: 
POSITIVE: Distinct purple line formed at the test zone marked 'T' (test line) 
and the control Zone marked 'C' (control line) the test result was positive,                    
indicating that the sample contains Hepatitis C Antigen. 
NEGATIVE: Distinct purple line formed only at the control zone marked 'C'                          
(Control line) the test result was negative. 
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Herpes Simplex Virus 2 –IgM ELISA from serum samples: 
IgM Capture ELISA kit from Diagnostic Bioprobes Italy 
Principle: 
The assay is based on the principle of "IgM capture" where IgM class antibodies 
in the sample are first captured by the solid phase coated with anti hIgM 
antibody. 
Procedure: 
10 µl of sample was diluted by adding 1mL sample diluent in a dilution 
tube and then mixed with vortex to diluted sample. The required number of 
Microwells on holder were placed. A1 is left empty for Blank sample. 100 µl of 
NC, 100 µl of Calibrator in duplicate were dispensed into respective wells. 100 
µl of PC was dispensed in single. Then 100 µl of samples were dispensed in 
respective wells. Wells are checked for blue color except A1. The strips were 
covered and incubated for 60 min at 37°C. Wells were washed for 5 cycles. 100 
µl of Ag/Ab Immunocomplex dispensed into each well except blank well. The 
strips were covered and Incubated for 60 min at 37°C.Washed for 5 cycles. 100 
µl of Chromogen/substrate mixture dispensed into each well including A1. 
Incubated for 20 min at 25°C. 100 µl of Sulphuric acid as stopping solution was 
dispensed into all the wells. PC & Positive samples turned from blue to yellow. 
OD value measured at 450nm filter, 620-630 nm (background substraction). 
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Herpes Simplex Virus 2 –IgG ELISA from serum samples: 
IgM Capture ELISA kit from Diagnostic Bioprobes Italy 
Principle: 
The assay is based on the principle of "IgG capture" where IgM class antibodies 
in the sample are first captured by the solid phase coated with anti hIgG 
antibody. 
Procedure: 
Microplates in the kit are coated with synthetic HSV2 specific 
glycoprotein G or gG.To the 10 µl of sample 1mL sample diluent is added in to 
a dilution tube. Then vortexed to dilute the sample. The required number of 
Microwells on holder were placed. A1 left empty for Blanking. 100 µl of NC, 
100 µl of Calibrator in duplicate were dispensed into respective wells. 100 µl of 
PC was dispensed in single. Then 100 µl of samples were dispensed in 
respective wells. All the samples are checked for blue color except the blank. 
Samples were incubated for 60 min at 37°C. The strips were covered. Wells 
were washed for 5 cycles. 100 µl of Ag/Ab Immunocomplex dispensed into 
each well except blank well. The strips were covered. All the wells are checked 
for red color except A1. Incubated for 60 min at 37°C and washed for 5 cycles. 
100 µl of Chromogen/substrate mixture dispensed into each well including A1. 
Incubated for 20 min at 25°C. 100 µl of Sulphuric acid as stopping solution was 
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dispensed into all the wells. PC & Positive samples turned from blue to yellow. 
OD value measured at 450nm filter, 620-630 nm (backgroundsubstraction). 
ISOLATION OF CELLS FROM THE SWAB 
 The swabs placed in 70% ethanol test tube is vortex mixed to loosen the 
cells in the swab and then the swab was discarded .The test tube containing 70% 
ethanol and the collected cells is centrifuged at 8000 rpm for 1 minute so that 
the cells get deposited in the bottom of the tube. The 70% ethanol is discarded 
leaving the cell deposits in the tube to which 0.5ml of PBS buffer is added. The 
cell deposits is transferred to a 1.5ml micro centrifuge tube for DNA isolation. 
POLYMERASE CHAIN REACTION 
ISOLATION OF VIRAL NUCLEIC ACID 
PRINCIPLE: 
 Cells are lysed during a short incubation with chaotropic salt, which 
immediately inactivate all nucleases. Cellular nucleic acids bind selectively to 
special glass fibers pre-packed in the purification filter tubes. Bound nucleic 
acids are purified in a series of rapid ‘wash and spin’ steps to remove 
contaminating cellular components. 
 A special inhibitor removal buffer has been included which removes 
inhibitors from the preparation. Finally elution buffer releases the nucleic acids 
from the glass fiber. This simple method eliminates the need for the organic 
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solvent extractions and nucleic acid precipitation, allowing for rapid purification 
of many samples simultaneously. 
MATERIALS REQUIRED  
1. Micro pipette variable volume 0.5-10 , 10-100 and 100-1000 
2. Sterile pipette tips with aerosol barrier 2-20, 10-100 and 100-
1000 
3. Disposable powder free gloves 
4. Vortex mixer/ water bath 
5. Centrifuge with rotor for 1.5 ml reaction tube 
6. 1.5ml/ 2ml centrifuge tubes 
PROCEDURE: 
Before use all the reagents were thawed completely, mixed and centrifuged 
briefly. 
1. The following reagents are added to a nuclease free 1.5ml centrifuge 
tube: 
a. 200µl of lysis buffer  
b. 5µl of carrier RNA was added  
c. 200µl of cell Deposit 
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d. 20µl of proteinase K 
e. 5µl of internal template control 
2. Centrifuge tube was mixed immediately by inverting it. 
3. The tube is incubate at 56° C for 15min in the water bath. 
4. After taking the tube from incubator 300µl of 100% ethanol was added 
and mixed by a vortex for 30 sec.  
5. Then the tube was centrifuged for few seconds to bring down drops to 
bottom of the tube. 
6. Entire sample was then transferred into the pure-fast spin column.  
7. The pure fast spin column was centrifuged at 12000 rpm for 1 min.  
8. The flow-through was discarded and column was placed back into the 
same collection tube. 
9. To this, 500µl of 70% ethanol was added to the pure-fast spin column. 
10. The pure fast spin column was centrifuged at 12000 rpm for 1 min and 
the flow-through was discarded and column was placed back into the 
same collection tube. 
11. The empty spin column was attached with collection tube and centrifuged 
at 12000rpm for an additional 2 min (essential to avoid residual ethanol) 
and the collection tube was discarded. 
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12. The pure fast spin column was then transferred to a fresh 1.5ml micro 
centrifuge tube, to this, 50µl of elution buffer was added to the Centre of 
pure fast spin column membrane and incubate for 2 min at room 
temperature. 
13. The pure fast spin column and the centrifuge tube was centrifuged at 
12000rpm for 1 min and the pure fast spin column was then discarded.  
14. Now the centrifuge tube containing the eluted nucleic acid was stored at              
-80°C for later analysis. 
Preparation of agarose gel 
 2% agarose gel was prepared by adding two grams of agarose powder to 
100 ml of electrophoresis buffer, then heated in a microwave oven for 3 min, 
mixed until the agarose was evenly dissolved. After cooling to about   60°C.5 µl 
of ethidium bromide was added to 100 ml of the gel to enable visualization of 
DNA after electrophoresis. Ethidium bromide being carcinogen being handled 
with precaution.  
 A well-formed COMB/template was placed across the end of the casting 
tray which is covered with a cellophane tape in its both the ends and the freshly 
prepared gel was poured into the casting tray which act as a mold. This was let 
to solidify at room temperature. 
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Preparation of Electrophoretic buffer 
 Electrophoresis (TAE- Tris Acetic acid –EDTA) buffer was prepared in 
the 50x dilution. To prepare a 1000ml of buffer 980ml distilled water and 20ml 
of buffer is added and poured into the electrophoresis tank. After the gel has 
hardened enough, the gel was gently placed on the electrophoresis tank with 
buffer and was made sure that the gel was completely immersed in the buffer 
and comb was removed carefully from the gel. 
SEMI NESTED POLYMERASE CHAIN REACTION FOR HERPES 
SIMPLEX VIRUS 2  
MASTER MIX 
 Master mix is prepared taking 10µl of master mix and 10µl HSV2 primer 
mix for one sample and mixed together.20µl of this mixture is added to a 0.2ml 
PCR tubes to which 5µl of sample is added. Positive control and negative 
control are also added in the similar method. 
The primer sequence of the HSV2 used in this procedure is  
5'-GCGTTTCTGATCGACGACGCCT-3' 
5'-TTTTAACCGCCGCCAGCACGTT-3 
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Thermocycling 
 The 0.2ml tubes having the positive, negative controls and the sample are 
placed in the thermo cycler and the program has been set to run in the following 
steps. 
 1. Denaturation at 95
o
C for 30 seconds 
 2. Annealing at 54
o
C for 30 seconds 
 3. Primer extension at 72
o
C for 30seconds 
 4. Again step 1.the cycle is repeated for 35 times  
Gel electrophoresis 
 After the thermocycler finished the amplification cycles (35 cycles) the 
tubes are taken out from the thermocycler and then 5µl of DNA ladder, 20 µl 
sample, 20 µl negative control and positive controls and were loaded into the 
gel wells using micropipette. Electrical leads were connected to the 
electrophoresis tank. And the current was supplied with a voltage 150V so that 
negatively charged DNA migrate from cathode to anode. Gel running time was 
approximately the time taken by the gel loading dye to cover three fourth of 
distance in the gel. 
 After the gel electrophoresis, PCR products were observed using UV 
Transilluminator. The DNA ladder is a mixture of fragments with known size to 
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compare with the PCR fragments.Amplicons of size 111bp of glycoprotein G 
gene(gG) were consistent with viral DNA. 
MULTIPLEX POLYMERASE CHAIN REACTION FOR HUMAN 
PAPILLOMA VIRUS 16 AND 18 
MASTER MIX 
 Master mix is prepared taking 10µl of master mix and 10µl HPV16 &18 
primer mix for one sample and mixed together.20µl of this mixture is added to a 
0.2ml PCR tubes to which 5µl of sample is added. Positive control and negative 
control are also added in the similar method. 
The primer sequence of HPV16 & 18 used in this procedure are 
HPV16 
5'-GCAACAGTTACTGCGACGTGAGGT-3’ 
5'-CACACAACGGTTTGTTGTATTGCTGT-3' 
 
HPV18 
5'-TGATCTGTGCACGGAACTGAACAC-3' 
5'-TCAACGGTTTCTGGCACCGCAG-3' 
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Thermocycling 
 The 0.2ml tubes having the positive, negative controls and the sample are 
placed in the thermo cycler and the program has been set to run in the following 
steps. 
 1. Denaturation at 95
o
C for 30 seconds 
 2. Annealing at 54
o
C for 30 seconds 
 3. Primer extension at 72
o
C for 30seconds 
 4. Again step 1.the cycle is repeated for 35 times  
Gel electrophoresis 
 After the thermo cycler finished the amplification cycles (35 cycles) the 
tubes are taken out from the thermo cycler and then 5µl of DNA ladder, 20 µl 
sample, 20 µl negative control and positive controls and were loaded into the 
gel wells using micropipette. Electrical leads were connected to the 
electrophoresis tank. And the current was supplied with a voltage 150V so that 
negatively charged DNA migrate from cathode to anode. Gel running time was 
approximately the time taken by the gel loading dye to cover three fourth of 
distance in the gel. 
 After the gel electrophoresis, PCR products were observed using UV 
Transilluminator. The DNA ladder is a mixture of fragments with known size to 
compare with the PCR fragments.Amplicons of size 200bp and 300bp were 
consistent with HPV 16 E7 and 18 E7respectively were taken as positive 
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OBSERVATION & RESULTS 
Two hundred patients (female Sex Workers-114, Males who have Sex with 
Males-60, Transgenders-26) who were asymptomaticwererecruited and included 
in this studyfrom STD clinic. Specimens such as High Vaginal, Endocervical, 
Pharyngeal, rectal swabs and blood were collected and processed to detect 
etiological organismsat the Department of Microbiology. The results were 
analyzed as follows. 
 
Table-1: Age Distribution 
Age in 
years 
Males who 
have Sex with 
Males(MSM) 
 
Female Sex 
Workers(CSW) 
 
Trans 
genders(TG) 
Total 
18-20 3(5%) 1(0.8%) 0 4(2%) 
21-30 33(55%) 47(41.2) 18(69.2%) 98(49%) 
31-40 17(28.3%) 54(47.3%) 7(27%) 78(39%) 
41-50 7(11.4%) 12(10.5) 1(3.8%) 20(10%) 
Total 60 114 26 200(100%) 
P value  0.128 
 
The commonest age group among MSM  is 21-30(55%).Among the female Sex 
Workers (FSW) the commonest age group is 31-40(47.3%).In transgenders 
(TG)the commonest age group is21-30(69.2%) and the overall commonest age 
group in the high risk group is 21-30(49%). 
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1. Age Distribution 
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Table 2: Marital status 
Category Married Un 
married 
Separated Divorced Total 
Female Sex 
Workers 
48(42.2%) 40(35%) 24(21%) 2(1.8%) 114 
Males who have Sex 
with Males 
20(33.3%) 40(66.7%) 0 0 60 
Trans genders 0 26(100%) 0 0 26 
Total 68(34%) 106(53%) 24(12%) 2(1%) 200 
 
 Marital status among the high risk groups is that most of them are unmarried 
106(53%). 
 
2. High Risk Categories 
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Table-3: Sexual History 
 
TYPE Female Sex 
Workers 
Males who 
have Sex 
with Males 
Trans 
genders 
Total P value 
Heterosexualmode 114 0 0 114(57%) P < 0.01 
Homosexual 
mode 
0 40 26 66(33%) P < 0.05 
Bisexual mode 0 20 0 20(10%) P < 0.01 
 
Among the high risk groups the commonest mode of sex is heterosexual mode 
134(57%). 
 
3.Sexual History 
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Table-4: Mode of sex among homosexuals 
TYPE Males who 
have Sex 
with Males 
Trans 
genders 
Total 
  
Kothis 
Oro 
Receptive 
1(1.6%) 3(11.5%) 4 29 
(33.7) 
Ano 
Receptive 
0 0 0 
Ano/oro 
Receptive 
2(3.4%) 23(88.5%) 25 
Panthis Ano 
Insertive 
21(35%) 0 21 42 
(48.8%) 
Oro 
Insertive 
7(11.6%) 0 7 
Ano/oro 
Insertive 
14(23.4%) 0 14 
Double 
deckers 
Ano/oro 
Insertive 
&oro 
receptive 
15(25%) 0 15 15 
(17.5%) 
Total 60 26 86 86 
Df 20 
P value 0.001 
 
Male sex workers (MSWs) are classified into different categories based 
on identity, Gender, behavior, and profession. Based on identity they are 
categorized as “gay,” “bisexuals,” “Kothis,” (ano/oro, both receptive partner) or 
“Panthis” (ano/oro both insertive partners) and double decker (both ano/oro 
receptive and insertive) Among the MSMs the commonest group is Ano/oro 
Insertive (panthis) (48.4%) and the transgenders indulge in ano/oro receptive 
method 23 (88.5%).  
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Mode of sex among Homosexuals 
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Table-5: Protective Measures & Blood Transfusion History 
Category Unprotected Protected H/O Blood 
Transfusion 
Female Sex Workers 43 71 1 
Males who have Sex 
with Males 
23 37 1 
Trans genders 16 10 0 
Total 82(41%) 118(59%) 2(1%) 
 
Protected last sexual contact was seen in 118(59%) and persons with the history 
of blood transfusion is 2 (1%) 
Protective Measures & Blood Transfusion History 
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Table -6: Sex Reassignment Surgery (SRS) 
Category SRS done SRS not done 
Trans genders 18 8 
Total 18 8 
Percentage 69.2% 30.8% 
 
Among the transgenders the number of persons undergone Sex Reassignment 
Surgery (SRS) was 18(69.2%) 
Sex Reassignment Surgery (SRS) 
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Table-7: Nature of specimens among High risk group  
Category Pharyngeal 
Swab 
Rectal 
Swab 
Endocervical 
Swab 
High 
Vaginal 
Swab 
Urethral 
swabs 
Blood 
female 
Sex 
Workers 
23 00 114 114 0 114 
Males 
who have 
Sex with 
Males 
60 24 00 00 60 60 
Trans 
genders 
26 26 00 00 0 26 
Total 109 49 114 114 60 200 
 
Among the high risk groups endocervical, high vaginal swab was collected 
114patients. In the Males who have Sex with Males pharyngeal swabs was 
collected predominantly (60) and rectal swab in 24.In the transgenders 
pharyngeal and rectal swab was collected for all of them (24).The blood was 
collected from all the group (200). 
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Table 8: Positivity in Direct examinations 
Tests 
done 
Positive findings High 
Vaginal 
Swab 
(114) 
Pharynge
al Swab    
(109) 
Rectal 
Swab 
(49) 
Endo 
cervica
l Swab 
(114) 
Uret
hral 
swa
bs 
(60) 
Total 
Wet 
mount 
(114) 
Clue cells 6(5.2%) - - - - 6 
Yeast cells with/without 
budding mycelium 
17 
(14.9%) 
1 - - - 18 
Motile Trichomonads 1 - - - - 1 
10% 
KOH 
mount 
(114) 
Yeast cells with/without 
budding mycelium 
17 1 - - - 18 
Fishy odour/Amine test 6 - - - - 6 
Gram 
Stain 
(446) 
Epithelial cells with 
lactobacillus 
110 - - - - 110 
Clue cells 6 - - - - 6 
Nugent 
score 
(7-10) 
Lactobacillus 
1-4,<1 
4 - - - - 4 
Mobiluncus 
>5,1-4 
4 
Gardernerella 
5-30,>30 
4 
Pus cells & Intra cellular 
Gram negative 
diplococci 
 - 1 - - 1 
Yeast cells with/without 
budding mycelium 
17 1 - - - 18 
 
Among the high vaginal swabs (114) collected in female Sex workers, the wet 
mount examination showed clue cells in 6(5.2%) which is in accordance with 
gram staining, Yeast cells with/without budding mycelium was seen in 
17(14.9%) which is in accordance with 10% KOH mount and motile 
trichomonads was seen in 1(0.5%).Gram staining of the specimens collected 
showed Pus cells & Intra cellular Gram negative diplococci in 1(2%) in rectal 
swab and although the gram staining showed clue cells in 6(5.2%) .Nugent’s 
score of 7 to 10 was seen in only 4(3.5%). 
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Table-9: Culture positivity 
Culture Done Result Female Sex 
Workers 
(114) 
Males 
who have 
Sex with 
Males 
(60) 
Trans 
genders 
(26) 
Total (200) 
Modified Thayer 
martin 
medium(200) 
Positive  0 0 1(Rectal) 1(0.5%) 
Human Blood 
Tween 80 Bilayer 
Medium(114) 
Positive  4 0 0 4(3.5%) 
CPLM 
medium(200) 
Positive  1 0 0 1 
SDA agar(200) Positive  17 0 1 18(9%) 
CHROMagar 
agar(200) 
Positive  17 0 1 18(9%) 
 
Among the high risk groups the culture for Gonococci, Modified Thayer martin 
medium was positive in 1(0.5%) from the rectal swab of the Transgender. The 
culture for bacterial vaginosis Human Blood Tween 80 Bilayer Medium was 
positive in 4(3.5%) in female sex workers. The culture for Trichomoniasis, the 
CPLM medium was positive in 1(0.5%) in a female sex workers. The culture 
for candidiasis, SDA culture was positive in 18(9%). 
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Table-10: Agreement between Direct examination and Culture  
Culture /direct smear Female Sex 
Workers 
Males 
who have 
Sex with 
Males 
Trans 
genders 
Tota
l 
Gonorrhoeae Direct Gram Stain 
positive  
0 0 1
* 
1 
Culture Positive 0 0 1
*
 1 
Bacterial 
Vaginosis 
Direct Gram Stain 
positive 
6 0 0 6 
Culture Positive  4 0 0 4 
Trichomoniasis Direct wet mount 
positive  
1 0 0 1 
Culture Positive 1 0 0 1 
Candidiasis Direct Gram Stain 
positive  
17 0 1 18 
Culture Positive 17 0 1 18 
 *---Rectal 
There was 100% agreement between gram stain and culture of the Gonococci 
(1) and 100% agreement between gram stain and culture of the candidiasis (18) 
and also 100% agreement between wet mount and culture of the 
Trichomoniasis(1) whereas in the Bacterial vaginosis culture it is 4 out of 6 
(66.6%) 
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Table-11: Antimicrobial Susceptibility Testing forNeisseria gonorrhoeae 
Disk content   No of isolates 1(Rectal) 
Resistant  Intermediate  Susceptible 
Penicillin 10 IU R
* 
  
Ciprofloxacin 5µg R   
Azithromycin 15 µg R   
Tetracycline 30 µg  I*  
Ceftriaxone 30 µg  I  
Spectinomycin 100 µg   S* 
R-Resistant S-sensitive I -intermediate 
Isolate was resistant to Penicillin andsensitive to Spectinomycin. 
Table -12 Candida Speciation 
Candida Species Female Sex 
Workers 
Males who 
have Sex 
with Males 
Trans 
genders 
Total 
Candida albicans 9 0 0 9(50%) 
Candida krusei 4 0 1 5(27.8%) 
Candida glabrata 2 0 0 2(11.1%) 
Candida parapsilosis 2 0 0 2(11.1%) 
Candida tropicalis 0 0 0 0 
Total 17 0 1 18 
 
Candida albicans was 9(50%) and 50% of candida non albicans of which 
candida krusei 5(27.8%) is predominant. 
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Table-13: Positivity in Serological tests 
Test Done Female Sex 
Workers 
114 
Males 
who have 
Sex with 
Males  60 
Trans 
genders 
Total 
HIV test Known reactive 
on ART 
2(1%) 2(1%) 4(2%) 8(4%) 
reactive 0 0 0 0(0%) 
RPR Reactive 3(1.5%) 3(1.5%) 1(0.5%) 7(3.5%) 
TPHA Positive  3(1.5%) 3(1.5%) 1(0.5%) 7(3.5%) 
HBsAg 
rapid card 
Positive  1(0.5%) 0 0 1(0.5%) 
Hep C 
rapid card 
Positive  0 0 0 0(0%) 
ELISA 
IgM HSV2 
Positive  8(4%) 5(2.5%) 3(1.5%) 16(8%) 
ELISA IgG 
HSV2 
Positive  37(18.5) 19(9.5%) 11(5.5%) 67(33.5%) 
 
In the serological tests the known HIV patients on ART were 8(4%) and the 
RPR/TPHA positives were 7(3.5%) and the Hepatitis Surface antigen was seen 
in 1(0.5%).The ELISA for IgM HSV2 antibody was seen in 16(8%) and the IgG 
HSV2 antibody was seen 67(33.5%). 
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Table-14Results of Combined IgM &IgG HSV 2 capture ELISA 
Categories IgM 
Positive 
IgG 
Positive 
Both IgM & IgG 
Positive 
female Sex Workers 8 37 8 
Males who have Sex 
with Males 
5 19 5 
Trans genders 3 11 3 
Total 16(8%) 67(33.5%) 16(8%) 
 
IgM HSV2 was positive in 16(8%) and the IgG was positive in 67(33.5%) and 
the patients with both IgM and IgG are 16(8%).All the IgM positive patients are 
also IgGpositive. 
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Table-15: PCR for HSV2 from Anogenital swabs 
 
Results Female Sex 
Workers 
Males who 
have Sex 
with Males 
Trans 
genders 
Total 
Positive 10(5%) 6(3%) 4(2%) 20(10%) 
Negative 104 54 22 180(90%) 
Total 114 60 26 200 
Df 2 
Pearson Chi-Square 0.784 
 
The semi nested PCR for HSV2 showed positive in 20(10%) of which most of 
them are female sex workers 10(5%) 
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Table-16 
Comparison of PCR HSV2 Positive cases and Combined IgM & 
IgGCapture ELISA HSV 2 
Categories PCR 
HSV2Positive 
IgMPositive IgGPositive 
female Sex 
Workers 
10 8 37 
Males who 
have Sex with 
Males 
6 5 19 
Trans genders 4 3 11 
Total 20(10%) 16(8%) 67(33.5%) 
 
Among the 20 positive HSV2 PCRonly 16 cases were positive for IgM &IgG 
and all the PCR positive cases were IgG positive. 
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Table-17: PCR for HPV 16 & 18 from Anogenital swabs 
 
Results Female 
Sex 
Workers 
Males who 
have Sex 
with Males 
Trans 
genders 
Total 
HPV 16 Positive 2 0 0 2(1%) 
HPV 18 Positive 1 0 0 1(0.5%) 
HPV 16 & 18 Positive 1 0 0 1(0.5%) 
Total 4 0 0 4(2%) 
 
 HPV 16 was positive in 2 cases, HPV 18 positive in one and HPV 16 and 18 co 
infection in 1 (0.5%). 
 
Table-18: Co-infection 
Co-infection Frequency 
Female Sex 
Workers 
Males 
who have 
Sex with 
Males 
Trans 
genders 
Total 
Syphilis &HIV  0 0 1 1 
HSV 2&HIV  2 2 2 6 
HPV 16 & 18and HIV 1 0 0 1 
Candidiasis &HIV 0 0 1 1 
 
Among the high risk groups the co infection of Syphilis withHIV is 1(14.2%), 
co infection of HSV2 with HIV is 6(8.9%), co infection of HPV 16& 18 
withHIV is 1(25%) and the co infection of Candidiasis with HIV is 1(5.5%). 
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DISCUSSION 
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More than 1 million people acquire a sexually transmitted infection every 
day. It is estimated that about 500 million people acquire one of the four 
following sexually transmitted infections Chlamydia, Gonorrhoea, Syphilis and 
Trichomoniasis every year.The incidence of sexually transmitted viral infections 
has increased in the recent past which is due to the increased awareness of 
people seeking healthcare facilities, increased use of broad spectrum antibiotics 
and the effectiveness of syndromic approach of treatment
2
. 
More than 530 million people are living with HSV2 and more than 290 
million women have an HPV infection which is one of the most common 
STIs
30
.The risk of acquiring the STIs and spreading it to the community is more 
in the high risk groups because of the promiscuous sexual activity, unprotected 
sex and the young age group making them more vulnerable. 
A total of 200 high risk group patients were included in this study who 
were all asymptomatic at the time of study. Demographic information about the 
high risk groups like age group, marital status, sexual behavior were collected 
and appropriate samples were collected. Standard laboratory procedures were 
used for collection, transport and processing the samples. 
Among the high risk groups taken for study the female sex workers 
(57%) were the commonest among them compared to males having sex with 
males (30%) and transgenders (13%).The commonest age group among the high 
risk group is the   21-30(49%) since people will be more sexually active in this 
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age group and this is similar with the study by S Abarnadevi et al
31
 in which the 
commonest age group is 21-30(39%). 
In our study the marital status among the high risk groups is that most of 
them are unmarried 106(53%), married 68(34%) separated and divorced (13%). 
InBach et al study
33
 the prevalence of marital status among the high risk groups 
as unmarried (46.8%), married (14.2%) and separated and divorced (39%). 
In our study the predominant mode of sexual contact was heterosexual 
mode (57%), followed by homosexual mode (33%) and bisexual mode in 
10%.S Abarnadevi et al
31
study showed heterosexual mode (89.5%) homosexual 
mode (1.6%) and bisexual (4.6%) of patients. Heterosexual mode was 
predominant because of the fact that female sex workers had multiple sexual 
partners.  
Male sex workers (MSWs) are classified into different categories based 
on identity, Gender, behavior, and profession. Based on identity they are 
categorized as “gay,” “bisexuals,” “Kothis,” (ano/oro, both receptive partner) or 
“Panthis” (ano/oro both insertive partners) and double decker (both ano/oro 
receptive and insertive).In our study as per the identity there are 29(33.7%) 
Kothis and 42(48.8%) panthis and 15(17.5%) double decker. InBrahmam et al
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study it was shownto be Kothi (49.9%), panthi (7.7%) and double decker 
(28.5%).Among the MSMs the commonest group is Ano/oro Insertive (panthis) 
(48.4%) and in transgenders it is ano/oro receptive method 23 (88.5%). 
124 
 
In our study a history of protected last sexual contact (with condoms) was 
elicited in 59% and 41% had unprotected sexual act (without condoms) among 
the high risk groups patients which correlates with the study of S Wee et al
32 
where 55% used condoms during sex.Eventhough awareness about condom 
usage is present they cannot adhere to it due to - Impaired decision making 
about condom usage when they are under the influence of alcohol, 
inaccessibility of condom at the time of need and misbelief  that using condoms 
will reduce the pleasure during the act. 
Among the high risk groups in the female sex workers who were willing 
for genital examination the endocervical, high vaginal swab and blood was 
collected he pharyngeal swab was collected only for 23 because the female sex 
workers say they seldom indulge in oral sex and were not willing for pharyngeal 
swab .In the Males who have Sex with Males genital and pharyngeal swab was 
collected for ano/oro receptive and insertive groups and rectal swab is collected 
in 24,who had ano and oro receptive sex.  
In our study the analysis of direct examination of clinical specimen 
results were out of 223 wet mount done 6 showed clue cells (2.69%), 18 showed 
yeast cells with/without budding mycelium (8.07%) and motile trichomonads 
was 1(0.4%). Of 223 KOH mount 18 were positive for Yeast cells with/without 
budding mycelium (8.07) and among the 446 gram staining done 6 were 
positive for clue cells (1.35%) and 18 were positive for Yeast cells with/without 
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budding mycelium(4.03%) and one was positive for Pus cells & Intra cellular 
Gram negative diplococci(0.2%) 
Among the high risk groups the direct examination of the samples 
collected were in the pharyngeal swabs (109) wet mount positive for yeast cells 
with budding mycelium was one (0.9%) transgender which correlated with the 
gram staining. In the rectal swabs (49) collected, gram staining showed one 
sample (2%) positive for pus cells and Intra cellular Gram negative diplococci 
in a transgender. In the vaginal swabs collected the wet mount showed 6(5.2%) 
clue cells which correlated with the gram staining and the yeast cells with 
budding mycelium was seen in 17(14.9%) which correlated with the gram 
staining and the other vaginal smear showed normal epithelial cells with 
lactobacillus. 
 Tables11, 12 and 13 
Among the high risk groups the Modified Thayer martin medium culture 
positivity is one (0.5%) from the rectal swab of an asymptomatic transgender in 
whom the gram staining showed pus cells along with gram negative diplococci 
which is low when compared with Beena Thomas et al
41
 in which the 
prevalence is 4.7%. 
Among the female sex workers in our study the presence of clue cells in 
gram staining and wet mount was 6(5.2%) but the culture positivity and the 
Nugent’s score of 7 to 10 is 4(3.5%) .The correlation between culture method 
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and gram staining was 4 out of 6(66.6).In Spiegel et al
49
 the correlation was 49 
out of 60(81.6%).The prevalence of Bacterial vaginosis among the 
asymptomatic female sex workers  is 3.5% whereas in the study conducted by 
Wiset et al
42
the prevalence is 24-37% among the asymptomatic women. 
In our study the prevalence of Trichomoniasis among the high risk group 
is 1(0.5%) to which the wet mount also positive for motile trichomonads. Study 
by Nimisha D shethwala et al
43
showed prevalence of Trichomoniasis is 2%. 
In our study the correlation between culture method and gram staining for 
candidiasis was 100% which correlates with Omar AA et el
51
 in which the 
correlation was 94.9%. In our study the prevalence of candidiasis among the 
high risk groups is 18(9%) which is similar with the study of Nimisha D 
shethwala et al
43
 in which the prevalence is 10.33%. 
Candida speciation was done which revealed that candida albicans 
9(50%) and non albicans 9(50%)  of which  5(27.8%) is candida krusei, 
2(11.1%) is candida glabrata and candida parapsilosis is 2(11.1%) which 
correlates with the study by Luciene et al
44
 in which the prevalence candida 
albicans is 55.6% and non albicans prevalence is 44.4%..Earlier candida 
albicans was the predominant cause of candidiasis but now there has been 
increase in the prevalence of candida non albicans as the cause of candidiasis 
.This change in the etiological pattern should be taken in to consideration 
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because of the fact that non albicans are having increased resistance to the 
azoles which are used to treat the candidiasis 
Serological analysis of our study showed HIVprevalence in the female 
sex workers (1%), in MSMs (1%) and in transgenders (2%) which was low 
when compared to recent NACO
34
 statement that among men who have sex 
with men (MSM) and female sex workers (FSWs) it was 4.43% and 2.67% 
respectively. According to UNDP 
35
 among transgenders (TG) there is a very 
high HIV prevalence (17.5% to 41%) among them. In our study all the HIV 
infected patients are positive for IgG antibody against HSV2. 
 Rapid Plasma Reagin test and Treponema pallidum haemaggluttinin test 
was reactive for 3(1.5%) in female sex workers and 1(0.5%) in transgenders 
which is low when compared with UNDP 
35
 in which the prevalence of syphilis 
in transgenders is 13.6%.and the prevalence of syphilis in female sex workers is 
8.2% as per Uribe-Salas get al
36
 and the prevalence of syphilis among the men 
who have sex with men (MSM) is 3(1.5%) which is similar to the study by   
Pisani et al 
37
 in which the prevalence is 2%. 
Hepatitis B among the female sex workers is 1(0.5%) which is low when 
compared with Todd CS et al
38
 in which the prevalence is 6.54%. 
 Herpes simplex virus antibody IgM was seen in 16(8%) and the IgG 
antibody against HSV2 was 67(33.5%) estimated by Sandwich ELISA method. 
The prevalence of HSV2 in transgenders was 5.5% which is low when 
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compared with UNDP 
35 
in which the prevalence is 29%.Prevalence of HSV2 in 
female sex workers is 18.5% which correlates with S Navadeh et al
39 
in which 
the prevalence is 18%.  
 The semi nested PCR for HSV2 DNA from the anogenital swabs were 
shown to be positive in 20(10%) which correlates with the Elizabeth Tronstein 
et al
40
 in which the asymptomatic shedding of HSV2 DNA is 8.5%.Among the 
20 positive samples 10 are from endocervical swabs of female sex workers, 6 
penile swabs from men who have sex with men and 4 are from transgenders of 
which 3 are from the anal swabs and 1 from the pharyngeal swab. 
All the 20 PCR positive samples was IgG antibody positive whereas the 
IgM is positive in only 16(8%) cases which implies the evidence of viral 
shedding even in the absence of IgM antibodies. Thus the interpretation of 
serological antibodies results reveals only the tip of the iceberg. These facts 
warrant us to equip the molecular methods to know about the genital viral 
shedding in both symptomatic and asymptomatic patients. 
As per the study of Peter Leone et al
9
transmission of genital herpes 
frequently occurs during asymptomatic viral shedding. Famciclovir 250 mg bid 
has effectively decreased the incidence of both clinical and subclinical genital 
HSV shedding as per Peter Leone et al
9
.Adopting such a prophylactic strategy 
in the high risk group will help to reduce the spread of genital herpes infection 
and also reducing the risk of acquiring the HIV among themselves. 
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In our study the prevalence of Human Papilloma virus 16 and 18(High 
risk types) by the multiplex PCR was 4(2%) of which 2(1%) was HPV 16 
infected, one (0.5%) was coinfected with both HPV 16 and 18.It is low when 
compared Ishita Ghoshet al
29
 in which the prevalence of HPV types 16 and 18 
was observed to be 24.4%..  
In our study the prevalence of co infection between HIV and Syphilis 
among the high risk group in our study was 14.2% which correlates with the 
study of Nimisha D. Shethwala et al
43 
in which the prevalence of co infection 
was 14.28%. 
The co infection of HIV and HSV2 among the high risk groups was 
6(8.9%) which is more when compared with Yin YP et al
46
 in which the 
prevalence of coinfection is 3.2% whereas in the study by Nilanjan Chakraborty 
et al
47
 the prevalence of co infection between HSV2 and HIV is 47% 
The co infection between HIV and HPV in our study was 25% which 
correlates with the study by Oliver et al
48
 in which the prevalence of high risk 
human papilloma virus infection among the HIV positive individuals was 
24.5%.According to Karen et al
52 
bivalentHPV vaccine has been shown to 
protect against anal cancers caused by HPV types 16 and 18, which could 
reduce the prevalence of anal cancer in both men and women. Vaccination to be 
considered for high-risk groups that include FSW and MSM in order to 
implement a successful prevention of spread of disease
52
. 
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The prevalence of co infection between HIV and candidiasis in our study 
was 5.5% which is low when compared with Nimisha D. Shethwala et al
43
 in 
which the prevalence is 17.14%. One HIV reactive female sex worker is having 
both HPV 16 and HPV 18 infection which correlates with the fact that Human 
Immunodeficiency virus (HIV) positive women have significantly higher 
prevalence of genital squamous intraepithelial lesions and of multifocal HPV 
related diseases
29
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SUMMARY 
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This prospective study was conducted to find out the prevalenceof 
sexually transmitted infections with special preference to genital herpes 
infection and other microbial infections in the high risk groups attending STD 
clinic in a tertiary care hospital. Total of 200asymptomatic patients with 114 
female sex workers 60 males having sex with males and 26 transgenders who 
attended STD clinic in Tertiary care Hospital between September 2013 to 
September 2014 were included. 
 Among the high risk groups taken for study the female sex workers 
(57%) were the commonest and most of them are unmarried 106(53%) with 
predominant mode of sexual contact was heterosexual mode (57%) and 41% 
had unprotected sexual act (without condoms).Specimens like Endocervical, 
High vaginal discharge along with urethral, rectal and pharyngeal swabs and 
blood were collected. Even with repeated motivation among the high risk group 
the willingness for Specimens like rectal swabs was low because of which 
disease prevalence was not fully known.  These specimens were processed 
according to standard laboratory procedures to detect etiological pathogens. 
Out of 200asymptomatic cases Neisseria gonorrhoeae (1), Trichomonas 
vaginalis (1), Candidaspecies (18), Gardernerella vaginalis (4)were isolated. 
IgM IgM antibodiesfor Herpes simplexvirus 2 is (16) and IgG(67). Eight with 
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HIV reactivity, 1 with HbsAg and seven with RPR reactivity for Syphilis were 
present in the high risk groups. 
There was 100% agreement between direct gram staining and culture 
methods to detect Neisseria gonorrhoeae and the isolate was found to be 
resistant to Ciprofloxacin, Penicillin and Azithromycin and sensitive to 
Spectinomycin according to CLSI Disk diffusion method. 
There was 100% agreement between direct gram staining and culture 
methods to detect Trichomonas vaginalis. 
In candidiasis there was 100% agreement between direct gram stain and 
culture methods.Speciation of the candida species showed candida albicans 50% 
and non albicans 50%. 
In Bacterial vaginosis the agreement between Nugent scoring, culture and 
the direct gram staining was66.6%. 
The PCR analysis of the 200 anogenital swabs showed presence of 
Herpes simplex virus 2 DNA glycoprotein gG 20.Out of 20 PCR positives IgG 
antibody was positive in all whereas the IgM was positive in only 16 by which 
it was evident that there is genital viral shedding even in the absence of IgM 
antibodies. Thus the interpretation of serological antibodies results reveals only 
the tip of the iceberg so to know about the genital viral shedding in the patients 
the use of molecular methods like PCR is mandatory. 
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The PCR analysis of the 200 anogenital swabs showed the presence of 
Human Papilloma Virus 16 E7&E718 in 4 with one positive for both HPV 16 
and 18 coinfection. 
Among the 200 patients included in our study nine co infections exists 
(Herpes simplex virus 2with HIV in six, syphilis with HIV in one, HIV with 
Human Papilloma Virus 16& 18 bothin one and Candida krusei with HIV in 
one). 
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CONCLUSION 
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In this prospective study among the high risk groups the female sex 
workers (57%) were the commonest and most of them are unmarried 106(53%) 
with predominant heterosexual mode of contact (57%) and 41% had 
unprotected sexual act .The prevalence of sexually transmitted infections in the 
200 asymptomatic high risk groups was one rectal Neisseria gonorrhoeae, one 
Trichomonas vaginalis, eighteen Candida species, four Gardernerella vaginalis 
were isolated. Antibodies detected for Herpes simplex virus 2 is IgG in sixty 
seven and IgM in sixteen cases. Eight with HIV reactivity, one positive for 
HbsAg and seven with RPR reactivity for Syphilis were present in the high risk 
groups. 
Out of 20 PCR positives the IgM was positive in only 16.There was 
genital viral shedding even in the absence of IgM antibodies. So molecular 
methods are necessary to know about the genital viral shedding. 
The high risk Human Papilloma Virus 16 & 18 was seen in 4 among the 
high risk groups. 
This study showed unprotected sexual contact were high, so continuous 
efforts are needed to encourage individuals to adopt safer sexual practices by 
using condoms and to modify sexual behavior may substantially decrease the 
chance of STD transmission. Awareness among the FSW and MSM have to be 
emphasized on the significance of sexually transmitted infections. 
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Among the high risk groups the transgenders enrolled in the study were 
very low. Studies exclusively involving the transgenders will yield much data 
about the disease prevalence among this group. 
Since the high risk group is a bridging population constant efforts are 
required to encourage the high risk group to adhere safer sexual practices and 
prophylactic strategies regarding antiviral therapy for HSV2 infected 
individuals and vaccination for HPV to be considered in the high risk groups.  
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APPENDIX 
 
1) CHOCOLATE AGAR 
Ingredients: 
Nutrient agar base 30 gm. 
Distilled water 1000 ml. 
Sheep blood 100 ml. 
Procedure: 
1) Dissolve 30 g of Columbia agar base to 1 litre of distilled water in a 
flask. 
Heat in a stem sterilizer to dissolve it completely. 
2) Adjust the pH to 7.5 – 7.6. 
3) Sterilize by autoclaving at 121° C for 15 minutes. 
4) Cool to 70° C in a water bath. 
5) Aseptically add 100 ml of sheep blood to it and leave at 70° C for 30 
minutes. 
6) Mix the blood and agar by gentle agitation from time to time till blood 
becomes chocolates brown in colour. This takes about 10 minutes. 
7) Pour as slopes or plates in sterile tubes or sterile Petri dishes. 
2) MODIFIED THAYER MARTIN MEDIUM WITH VCNT 
INHIBITORS 
A selective medium for the growth of N. gonorrhoeae. 
Ingredients: 
1) MTM agar base 21 gm 
2) 2% Hemoglobin solution 250 ml 
3) Distilled water 450 ml. 
4) VCNT inhibitor 10ml 
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i) Vancomycin 2.0 to 4.0 mg or Lincomycin 1 mg/litre 
ii) Colistin 300.000 units to 7.5 mg/litre 
iii) Nystain 12.5 IU/ml 
iv)Trimethoprim 2mg/litre. 
Procedure: 
1) Mix 21 gms MTM agar in 450 ml of distilled water by boiling. 
2) Sterilize by autoclaving at 121° C for 15 minutes. 
3) Cool to a temperature of 50‐55° C in a waterbath. 
4) Aseptically add freshly prepared 250 ml of 2% hemoglobin 
solutionand  
VCNT nhibitor to and mix well. 
5) Pour 20 ml of medium in a sterile Petri dish of 90 mm diameterunder  
strict aseptic precautions. 
6) Allow the medium to cool and store in refrigerator. 
3) PHOSPHATE BUFFERED SALINE: 
Ingredients: 
NaCl 9.0 gm 
Potassium chloride 0.2 gm 
Disodium hydrogen phosphate 1.15 gm 
Potassium dihydrogen phosphate 0.2 gm 
Distilled water 1000 ml 
Mix the salts in distilled water. It gives a final pH 7.3. 
4) SABOURAUD’S DEXTROSE AGAR 
Ingredients: 
Dextrose 40.0 gm 
Neopeptone 10.0 gm 
Agar 15.0 gm 
Distilled water 1000 ml 
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Procedure: 
1) Mix the ingredients in distilled water by boiling. Adjust pH to 5.6. 
2) Sterilize by autoclaving at 115° C for 15 min. 
3) Allow to cool to 50° C. 
4) Add Chloramphenicol 1 mg/ml of medium under aseptic precautions. 
5) Pour 20 ml amounts in 90mm Petri dish or into 15 ml test tubes. 
6) Allow the test tubes to rest at an angle so that agar slopes (slants) are 
obtained. 
7) After the medium solidifies, keep the Petri dish and cotton 
woolstopped  
dextrose agar slants in the refrigerator. 
5) DIAMOND’S TRICHOMONAS MEDIUM 
Ingredients: 
Trypticase 20.0 gm 
Yeast extract 10.0 gm 
Maltose 5.0 gm 
L‐Cysteine hydrochloride 1.0 gm 
L‐Ascorbic acid 0.2 gm 
Di‐potassium hydrogen phosphate 0.8 gm 
Potassium dihydrogen phosphate 0.5 gm 
Agar 0.5 gm 
Distilled water 900 ml 
Procedure: 
1) Mix the contents in distilled water. 
2) Autoclave the medium at 115°C for 20 minutes. 
3) Cool the medium to 50° C and add 100 ml sheep or bovine serum 
(Sterilized by filtration) and 10 mgs % Chloramphenicol. 
4) Store at 4° C till use. 
142 
 
6) Nutrient Agar 
Ingredients Grams/litre 
Peptic digest of animal tissue 5 
Sodium Chloride 5 
Beef extract 1.5 
Yeast extract 1.5 
Agar 15.00 
Final pH(at 25º C) 7.4 ±0.2. 
Suspend 28 gms in 1000 ml of distilled water. Heat toboiling to dissolve the  
medium completely. Sterilize byautoclaving at 15 lbs pressure (121ºC) for 15  
minutes andpour into sterile petridishes. 
7.) HBT Bilayer Medium Blood agar with Tween 80 
Pancreatic Digest of Casein12.0 g 
Peptic Digest of Animal Tissue 5.0 g 
Yeast Extract 3.0 g 
Beef Extract3.0 g 
Peptone 10.0 g 
Corn Starch1.0 g 
Sodium Chloride5.0 g 
Agar13.5 g 
Polysorbate 80 0.075 g 
Colistin10.0 mg 
Nalidixic Acid20.0 mg 
Amphotericin B3.0 mg 
Human Blood, Anti coagulated (top layer only) 10% 
PROCEDURE  
HB(humanbloodbilayer)medium was composed ofabasallayerof7mlof CNA  
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Agarbase,withamphotericinB(2p.g/ml)Addedafterautoclavingwasperformed 
anda14-mlover layerofthesamecomposition plus 5% humanblood.1%Proteose 
PeptoneNo.3 was addedtobothlayersbeforeautoclavingwasperformed,and 
.0075%Tween80 was addedtobothlayersafterautoclavingwas performed. 
8) CHROMagar Candida 
REAGENTS 
Chromopeptone10.0 g 
Glucose 20.0 g 
Chromogen Mix2.0 g 
Chloramphenicol.0.5 g 
Agar15.0 g 
Suspend 47.5gms in 1000 ml of distilled water. Heat to boiling to dissolve the  
medium completely. Sterilize by autoclaving at 15 lbs pressure (121ºC) for 15  
minutes and pour into sterile petridishes. 
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KEY TO MASTER CHART 
FSW-female sex workers 
MSM-Males who have sex with males 
TG-Transgenders 
ART-Antiretroviral therapy  
SRS-Sex Reassignment Surgery 
A/O-anal and Oral 
LMC‐last marital contact 
PMC‐premarital contact 
Prot‐protected intercourse with condom 
Unprot‐unprotected intercourse 
SURG-Surgery 
BLD TRANS-Blood transfusion 
END CX-Endocervical 
H.VAGN-High vaginal 
KOH-Potassium hydroxide 
BYC‐budding yeast cell 
Intra cell GNDC‐intra cellular gram negative diplococcic 
GC cul‐gonococcus culture 
BV-Bacterial vaginosis 
CPLM-Cysteine, peptic digest, Liver digest and Maltose 
SDA‐Sabourads dextrose agar 
TV‐Trichomonas vaginalis 
HIV‐Human Immuno Deficiency Virus 
RPR‐Rapid Plasma Reagin 
TPHA-Treponema pallidum haemaggluttinin  
HbsAg-Hepatitis B surface antigen 
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HCV-Hepatitis C virus 
HSV IgM‐Herpes simplex virus 2 IgM ELISA 
HSV IgG‐Herpes simplex virus 2 IgG ELISA 
HPV-Human Papilloma virus 
PCR-Polymerase Chain reaction 
NR – Non reactive 
Neg – Negative 
Pos – Positive 
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